WO2024102900A1 - Methods of making shape stable phase change material compositions - Google Patents
Methods of making shape stable phase change material compositions Download PDFInfo
- Publication number
- WO2024102900A1 WO2024102900A1 PCT/US2023/079215 US2023079215W WO2024102900A1 WO 2024102900 A1 WO2024102900 A1 WO 2024102900A1 US 2023079215 W US2023079215 W US 2023079215W WO 2024102900 A1 WO2024102900 A1 WO 2024102900A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- component
- crosslinking
- phase change
- linker
- combining
- Prior art date
Links
- 239000012782 phase change material Substances 0.000 title claims abstract description 79
- 238000000034 method Methods 0.000 title claims abstract description 72
- 239000000203 mixture Substances 0.000 title description 101
- 238000004132 cross linking Methods 0.000 claims abstract description 90
- 239000011159 matrix material Substances 0.000 claims abstract description 72
- 238000006243 chemical reaction Methods 0.000 claims abstract description 28
- 230000009969 flowable effect Effects 0.000 claims abstract description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 44
- 238000000265 homogenisation Methods 0.000 claims description 40
- 229920001282 polysaccharide Polymers 0.000 claims description 32
- 239000005017 polysaccharide Substances 0.000 claims description 32
- 239000012530 fluid Substances 0.000 claims description 29
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 9
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 6
- 230000005484 gravity Effects 0.000 claims description 6
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 3
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-ZXXMMSQZSA-N D-iditol Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-ZXXMMSQZSA-N 0.000 claims description 3
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-threitol Chemical compound OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 claims description 3
- 239000004386 Erythritol Substances 0.000 claims description 3
- 229930195725 Mannitol Natural products 0.000 claims description 3
- JVWLUVNSQYXYBE-UHFFFAOYSA-N Ribitol Natural products OCC(C)C(O)C(O)CO JVWLUVNSQYXYBE-UHFFFAOYSA-N 0.000 claims description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 3
- 150000002016 disaccharides Chemical class 0.000 claims description 3
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 3
- 235000019414 erythritol Nutrition 0.000 claims description 3
- 229940009714 erythritol Drugs 0.000 claims description 3
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 claims description 3
- 239000000905 isomalt Substances 0.000 claims description 3
- 235000010439 isomalt Nutrition 0.000 claims description 3
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims description 3
- 239000000832 lactitol Substances 0.000 claims description 3
- 235000010448 lactitol Nutrition 0.000 claims description 3
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 claims description 3
- 229960003451 lactitol Drugs 0.000 claims description 3
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 3
- 235000010449 maltitol Nutrition 0.000 claims description 3
- 239000000845 maltitol Substances 0.000 claims description 3
- 229940035436 maltitol Drugs 0.000 claims description 3
- 239000000594 mannitol Substances 0.000 claims description 3
- 235000010355 mannitol Nutrition 0.000 claims description 3
- 150000002772 monosaccharides Chemical class 0.000 claims description 3
- 229920001542 oligosaccharide Polymers 0.000 claims description 3
- 150000002482 oligosaccharides Chemical class 0.000 claims description 3
- 229920005862 polyol Polymers 0.000 claims description 3
- 150000003077 polyols Chemical class 0.000 claims description 3
- HEBKCHPVOIAQTA-ZXFHETKHSA-N ribitol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)CO HEBKCHPVOIAQTA-ZXFHETKHSA-N 0.000 claims description 3
- 239000000600 sorbitol Substances 0.000 claims description 3
- 239000000811 xylitol Substances 0.000 claims description 3
- 235000010447 xylitol Nutrition 0.000 claims description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 3
- 229960002675 xylitol Drugs 0.000 claims description 3
- 150000004676 glycans Chemical class 0.000 claims 1
- 125000005647 linker group Chemical group 0.000 description 61
- 239000000463 material Substances 0.000 description 49
- 239000004971 Cross linker Substances 0.000 description 31
- -1 galactomannan polysaccharide Chemical class 0.000 description 30
- 150000004804 polysaccharides Chemical class 0.000 description 29
- 230000000845 anti-microbial effect Effects 0.000 description 17
- 239000000945 filler Substances 0.000 description 17
- 230000008859 change Effects 0.000 description 16
- 239000002608 ionic liquid Substances 0.000 description 16
- 239000003063 flame retardant Substances 0.000 description 15
- 229960001231 choline Drugs 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000004599 antimicrobial Substances 0.000 description 13
- 235000014113 dietary fatty acids Nutrition 0.000 description 13
- 239000000194 fatty acid Substances 0.000 description 13
- 229930195729 fatty acid Natural products 0.000 description 13
- 150000004665 fatty acids Chemical class 0.000 description 13
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 10
- 239000010457 zeolite Substances 0.000 description 10
- 229910021536 Zeolite Inorganic materials 0.000 description 9
- 125000005907 alkyl ester group Chemical group 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 241000894007 species Species 0.000 description 8
- 150000002191 fatty alcohols Chemical class 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 241001474374 Blennius Species 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 235000010443 alginic acid Nutrition 0.000 description 6
- 229920000615 alginic acid Polymers 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000004146 energy storage Methods 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- CXHHBNMLPJOKQD-UHFFFAOYSA-N methyl hydrogen carbonate Chemical compound COC(O)=O CXHHBNMLPJOKQD-UHFFFAOYSA-N 0.000 description 6
- 239000011575 calcium Substances 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 4
- XIEPJMXMMWZAAV-UHFFFAOYSA-N cadmium nitrate Chemical compound [Cd+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O XIEPJMXMMWZAAV-UHFFFAOYSA-N 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 125000005442 diisocyanate group Chemical group 0.000 description 4
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 4
- 150000005846 sugar alcohols Chemical class 0.000 description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 3
- 244000215068 Acacia senegal Species 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- 229920001661 Chitosan Polymers 0.000 description 3
- 244000259229 Grindelia squarrosa Species 0.000 description 3
- 229920002907 Guar gum Polymers 0.000 description 3
- 229920000084 Gum arabic Polymers 0.000 description 3
- 229920000161 Locust bean gum Polymers 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 235000010489 acacia gum Nutrition 0.000 description 3
- 239000000205 acacia gum Substances 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 229940072056 alginate Drugs 0.000 description 3
- 239000000783 alginic acid Substances 0.000 description 3
- 229960001126 alginic acid Drugs 0.000 description 3
- 150000004781 alginic acids Chemical class 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 3
- 239000004327 boric acid Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 229920003086 cellulose ether Polymers 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 235000010417 guar gum Nutrition 0.000 description 3
- 239000000665 guar gum Substances 0.000 description 3
- 229960002154 guar gum Drugs 0.000 description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N heptadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 239000000416 hydrocolloid Substances 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 235000010420 locust bean gum Nutrition 0.000 description 3
- 239000000711 locust bean gum Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 229940032147 starch Drugs 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- ZXMGHDIOOHOAAE-UHFFFAOYSA-N 1,1,1-trifluoro-n-(trifluoromethylsulfonyl)methanesulfonamide Chemical compound FC(F)(F)S(=O)(=O)NS(=O)(=O)C(F)(F)F ZXMGHDIOOHOAAE-UHFFFAOYSA-N 0.000 description 2
- ZXHZWRZAWJVPIC-UHFFFAOYSA-N 1,2-diisocyanatonaphthalene Chemical compound C1=CC=CC2=C(N=C=O)C(N=C=O)=CC=C21 ZXHZWRZAWJVPIC-UHFFFAOYSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- FLIACVVOZYBSBS-UHFFFAOYSA-N Methyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC FLIACVVOZYBSBS-UHFFFAOYSA-N 0.000 description 2
- HPEUJPJOZXNMSJ-UHFFFAOYSA-N Methyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC HPEUJPJOZXNMSJ-UHFFFAOYSA-N 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- WQZGKKKJIJFFOK-PQMKYFCFSA-N alpha-D-mannose Chemical compound OC[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-PQMKYFCFSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000001588 bifunctional effect Effects 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- UFMZWBIQTDUYBN-UHFFFAOYSA-N cobalt dinitrate Chemical compound [Co+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O UFMZWBIQTDUYBN-UHFFFAOYSA-N 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- UQGFMSUEHSUPRD-UHFFFAOYSA-N disodium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane Chemical compound [Na+].[Na+].O1B([O-])OB2OB([O-])OB1O2 UQGFMSUEHSUPRD-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 238000007306 functionalization reaction Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000005338 heat storage Methods 0.000 description 2
- FIPPFBHCBUDBRR-UHFFFAOYSA-N henicosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCO FIPPFBHCBUDBRR-UHFFFAOYSA-N 0.000 description 2
- IRHTZOCLLONTOC-UHFFFAOYSA-N hexacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCO IRHTZOCLLONTOC-UHFFFAOYSA-N 0.000 description 2
- XMHIUKTWLZUKEX-UHFFFAOYSA-N hexacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O XMHIUKTWLZUKEX-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 2
- 150000004677 hydrates Chemical class 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N icosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- UQDUPQYQJKYHQI-UHFFFAOYSA-N methyl laurate Chemical compound CCCCCCCCCCCC(=O)OC UQDUPQYQJKYHQI-UHFFFAOYSA-N 0.000 description 2
- ZAZKJZBWRNNLDS-UHFFFAOYSA-N methyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OC ZAZKJZBWRNNLDS-UHFFFAOYSA-N 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- XGFDHKJUZCCPKQ-UHFFFAOYSA-N nonadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCO XGFDHKJUZCCPKQ-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- REIUXOLGHVXAEO-UHFFFAOYSA-N pentadecan-1-ol Chemical compound CCCCCCCCCCCCCCCO REIUXOLGHVXAEO-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- NVIFVTYDZMXWGX-UHFFFAOYSA-N sodium metaborate Chemical compound [Na+].[O-]B=O NVIFVTYDZMXWGX-UHFFFAOYSA-N 0.000 description 2
- 235000010339 sodium tetraborate Nutrition 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- TYWMIZZBOVGFOV-UHFFFAOYSA-N tetracosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCO TYWMIZZBOVGFOV-UHFFFAOYSA-N 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 229910052723 transition metal Inorganic materials 0.000 description 2
- 150000003624 transition metals Chemical class 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 2
- KJIOQYGWTQBHNH-UHFFFAOYSA-N undecanol Chemical compound CCCCCCCCCCCO KJIOQYGWTQBHNH-UHFFFAOYSA-N 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 150000003754 zirconium Chemical class 0.000 description 2
- 229910052726 zirconium Inorganic materials 0.000 description 2
- 150000003755 zirconium compounds Chemical class 0.000 description 2
- OERNJTNJEZOPIA-UHFFFAOYSA-N zirconium nitrate Chemical compound [Zr+4].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O OERNJTNJEZOPIA-UHFFFAOYSA-N 0.000 description 2
- WDQLRUYAYXDIFW-RWKIJVEZSA-N (2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-4-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 WDQLRUYAYXDIFW-RWKIJVEZSA-N 0.000 description 1
- 239000001149 (9Z,12Z)-octadeca-9,12-dienoate Substances 0.000 description 1
- WTTJVINHCBCLGX-UHFFFAOYSA-N (9trans,12cis)-methyl linoleate Natural products CCCCCC=CCC=CCCCCCCCC(=O)OC WTTJVINHCBCLGX-UHFFFAOYSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-REOHCLBHSA-M (S)-lactate Chemical compound C[C@H](O)C([O-])=O JVTAAEKCZFNVCJ-REOHCLBHSA-M 0.000 description 1
- KZWJWYFPLXRYIL-UHFFFAOYSA-M 1,1,2,2-tetrafluoroethanesulfonate Chemical compound [O-]S(=O)(=O)C(F)(F)C(F)F KZWJWYFPLXRYIL-UHFFFAOYSA-M 0.000 description 1
- XFRVVPUIAFSTFO-UHFFFAOYSA-N 1-Tridecanol Chemical compound CCCCCCCCCCCCCO XFRVVPUIAFSTFO-UHFFFAOYSA-N 0.000 description 1
- BSKSXTBYXTZWFI-UHFFFAOYSA-M 1-butyl-3-methylimidazol-3-ium;acetate Chemical compound CC([O-])=O.CCCC[N+]=1C=CN(C)C=1 BSKSXTBYXTZWFI-UHFFFAOYSA-M 0.000 description 1
- WPHIMOZSRUCGGU-UHFFFAOYSA-N 1-butyl-3-methylimidazol-3-ium;nitrate Chemical compound [O-][N+]([O-])=O.CCCCN1C=C[N+](C)=C1 WPHIMOZSRUCGGU-UHFFFAOYSA-N 0.000 description 1
- SIXHYMZEOJSYQH-UHFFFAOYSA-M 1-butyl-3-methylimidazol-3-ium;thiocyanate Chemical compound [S-]C#N.CCCCN1C=C[N+](C)=C1 SIXHYMZEOJSYQH-UHFFFAOYSA-M 0.000 description 1
- KVBQNFMTEUEOCD-UHFFFAOYSA-M 1-butylpyridin-1-ium;bromide Chemical compound [Br-].CCCC[N+]1=CC=CC=C1 KVBQNFMTEUEOCD-UHFFFAOYSA-M 0.000 description 1
- RQVJLVQTNZVVRZ-UHFFFAOYSA-M 1-dodecyl-3-methylimidazol-3-ium;iodide Chemical compound [I-].CCCCCCCCCCCCN1C=C[N+](C)=C1 RQVJLVQTNZVVRZ-UHFFFAOYSA-M 0.000 description 1
- STCBHSHARMAIOM-UHFFFAOYSA-N 1-methyl-1h-imidazol-1-ium;chloride Chemical compound Cl.CN1C=CN=C1 STCBHSHARMAIOM-UHFFFAOYSA-N 0.000 description 1
- KLFDZFIZKMEUGI-UHFFFAOYSA-M 1-methyl-3-prop-2-enylimidazol-1-ium;bromide Chemical compound [Br-].C[N+]=1C=CN(CC=C)C=1 KLFDZFIZKMEUGI-UHFFFAOYSA-M 0.000 description 1
- 229960002666 1-octacosanol Drugs 0.000 description 1
- QLKGUVGAXDXFFW-UHFFFAOYSA-M 2-hydroxyethyl(trimethyl)azanium;acetate Chemical compound CC([O-])=O.C[N+](C)(C)CCO QLKGUVGAXDXFFW-UHFFFAOYSA-M 0.000 description 1
- ZFQCFWRSIBGRFL-UHFFFAOYSA-B 2-hydroxypropane-1,2,3-tricarboxylate;zirconium(4+) Chemical compound [Zr+4].[Zr+4].[Zr+4].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O ZFQCFWRSIBGRFL-UHFFFAOYSA-B 0.000 description 1
- LYPJRFIBDHNQLY-UHFFFAOYSA-J 2-hydroxypropanoate;zirconium(4+) Chemical compound [Zr+4].CC(O)C([O-])=O.CC(O)C([O-])=O.CC(O)C([O-])=O.CC(O)C([O-])=O LYPJRFIBDHNQLY-UHFFFAOYSA-J 0.000 description 1
- LNJCGNRKWOHFFV-UHFFFAOYSA-N 3-(2-hydroxyethylsulfanyl)propanenitrile Chemical compound OCCSCCC#N LNJCGNRKWOHFFV-UHFFFAOYSA-N 0.000 description 1
- DTSDUBQXWJFKTP-UHFFFAOYSA-N 4-(3-butylimidazol-1-ium-1-yl)butane-1-sulfonate Chemical compound CCCCN1C=C[N+](CCCCS([O-])(=O)=O)=C1 DTSDUBQXWJFKTP-UHFFFAOYSA-N 0.000 description 1
- PJGSRNRRFJTJNK-UHFFFAOYSA-N 4-[3-(3-cyanopropyl)imidazol-3-ium-1-yl]butanenitrile Chemical compound N#CCCCN1C=C[N+](CCCC#N)=C1 PJGSRNRRFJTJNK-UHFFFAOYSA-N 0.000 description 1
- ACFNVKKYJRDMAS-UHFFFAOYSA-M 4-[3-(3-cyanopropyl)imidazol-3-ium-1-yl]butanenitrile;chloride Chemical compound [Cl-].N#CCCCN1C=C[N+](CCCC#N)=C1 ACFNVKKYJRDMAS-UHFFFAOYSA-M 0.000 description 1
- DUFCMRCMPHIFTR-UHFFFAOYSA-N 5-(dimethylsulfamoyl)-2-methylfuran-3-carboxylic acid Chemical compound CN(C)S(=O)(=O)C1=CC(C(O)=O)=C(C)O1 DUFCMRCMPHIFTR-UHFFFAOYSA-N 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- MZLJSTIGVDEZLD-UHFFFAOYSA-L C(C(=O)[O-])(=O)[O-].[Na+].[Zr+4] Chemical compound C(C(=O)[O-])(=O)[O-].[Na+].[Zr+4] MZLJSTIGVDEZLD-UHFFFAOYSA-L 0.000 description 1
- UMZXEKFNURNTSQ-UHFFFAOYSA-M C(C(=O)[O-])(=O)[O-].[Zr+].[NH4+] Chemical compound C(C(=O)[O-])(=O)[O-].[Zr+].[NH4+] UMZXEKFNURNTSQ-UHFFFAOYSA-M 0.000 description 1
- WRAGBEWQGHCDDU-UHFFFAOYSA-M C([O-])([O-])=O.[NH4+].[Zr+] Chemical compound C([O-])([O-])=O.[NH4+].[Zr+] WRAGBEWQGHCDDU-UHFFFAOYSA-M 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- RUPBZQFQVRMKDG-UHFFFAOYSA-M Didecyldimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC RUPBZQFQVRMKDG-UHFFFAOYSA-M 0.000 description 1
- OJIYIVCMRYCWSE-UHFFFAOYSA-M Domiphen bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CCOC1=CC=CC=C1 OJIYIVCMRYCWSE-UHFFFAOYSA-M 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920001612 Hydroxyethyl starch Polymers 0.000 description 1
- RAXXELZNTBOGNW-UHFFFAOYSA-O Imidazolium Chemical compound C1=C[NH+]=CN1 RAXXELZNTBOGNW-UHFFFAOYSA-O 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 239000002879 Lewis base Substances 0.000 description 1
- 235000021353 Lignoceric acid Nutrition 0.000 description 1
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 description 1
- PKIXXJPMNDDDOS-UHFFFAOYSA-N Methyl linoleate Natural products CCCCC=CCCC=CCCCCCCCC(=O)OC PKIXXJPMNDDDOS-UHFFFAOYSA-N 0.000 description 1
- QWZLBLDNRUUYQI-UHFFFAOYSA-M Methylbenzethonium chloride Chemical compound [Cl-].CC1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 QWZLBLDNRUUYQI-UHFFFAOYSA-M 0.000 description 1
- 229910004835 Na2B4O7 Inorganic materials 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229940123573 Protein synthesis inhibitor Drugs 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- OLULCGRZLCPQGF-UHFFFAOYSA-M S(=O)(=O)([O-])[O-].[Zr+].[NH4+] Chemical compound S(=O)(=O)([O-])[O-].[Zr+].[NH4+] OLULCGRZLCPQGF-UHFFFAOYSA-M 0.000 description 1
- 229920002305 Schizophyllan Polymers 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- YSMRWXYRXBRSND-UHFFFAOYSA-N TOTP Chemical compound CC1=CC=CC=C1OP(=O)(OC=1C(=CC=CC=1)C)OC1=CC=CC=C1C YSMRWXYRXBRSND-UHFFFAOYSA-N 0.000 description 1
- WOURXYYHORRGQO-UHFFFAOYSA-N Tri(3-chloropropyl) phosphate Chemical compound ClCCCOP(=O)(OCCCCl)OCCCCl WOURXYYHORRGQO-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- FZQSLXQPHPOTHG-UHFFFAOYSA-N [K+].[K+].O1B([O-])OB2OB([O-])OB1O2 Chemical compound [K+].[K+].O1B([O-])OB2OB([O-])OB1O2 FZQSLXQPHPOTHG-UHFFFAOYSA-N 0.000 description 1
- OAJHWYJGCSAOTQ-UHFFFAOYSA-N [Zr].CCCCCCCCO.CCCCCCCCO.CCCCCCCCO.CCCCCCCCO Chemical compound [Zr].CCCCCCCCO.CCCCCCCCO.CCCCCCCCO.CCCCCCCCO OAJHWYJGCSAOTQ-UHFFFAOYSA-N 0.000 description 1
- BLGMKEFSVMUZCW-UHFFFAOYSA-N acetic acid;azane;zirconium Chemical compound N.[Zr].CC(O)=O BLGMKEFSVMUZCW-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- JEWHCPOELGJVCB-UHFFFAOYSA-N aluminum;calcium;oxido-[oxido(oxo)silyl]oxy-oxosilane;potassium;sodium;tridecahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.O.O.O.[Na].[Al].[K].[Ca].[O-][Si](=O)O[Si]([O-])=O JEWHCPOELGJVCB-UHFFFAOYSA-N 0.000 description 1
- JYIBXUUINYLWLR-UHFFFAOYSA-N aluminum;calcium;potassium;silicon;sodium;trihydrate Chemical compound O.O.O.[Na].[Al].[Si].[K].[Ca] JYIBXUUINYLWLR-UHFFFAOYSA-N 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229910052908 analcime Inorganic materials 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- VEGSIXIYQSUOQG-UHFFFAOYSA-N azane;2-hydroxypropanoic acid;zirconium Chemical compound [NH4+].[Zr].CC(O)C([O-])=O VEGSIXIYQSUOQG-UHFFFAOYSA-N 0.000 description 1
- RJMWSMMKKAJPGD-UHFFFAOYSA-L azanium;2-hydroxypropane-1,2,3-tricarboxylate;zirconium(2+) Chemical compound [NH4+].[Zr+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O RJMWSMMKKAJPGD-UHFFFAOYSA-L 0.000 description 1
- WNGFSLSVAFJVQG-UHFFFAOYSA-L azanium;zirconium(2+);phosphate Chemical compound [NH4+].[Zr+2].[O-]P([O-])([O-])=O WNGFSLSVAFJVQG-UHFFFAOYSA-L 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- CJJJLUVYFXOOSP-UHFFFAOYSA-N bis(trifluoromethylsulfonyl)azanide;1,3-diethoxyimidazol-1-ium Chemical compound CCON1C=C[N+](OCC)=C1.FC(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)F CJJJLUVYFXOOSP-UHFFFAOYSA-N 0.000 description 1
- VQKFGWWOHFMUPX-UHFFFAOYSA-N bis(trifluoromethylsulfonyl)azanide;1,3-dihydroxy-2-methylimidazol-1-ium Chemical compound CC=1N(O)C=C[N+]=1O.FC(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)F VQKFGWWOHFMUPX-UHFFFAOYSA-N 0.000 description 1
- SWVAEQIBLYMHDX-UHFFFAOYSA-N bis(trifluoromethylsulfonyl)azanide;1,3-dihydroxyimidazol-1-ium Chemical compound ON1C=C[N+](O)=C1.FC(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)F SWVAEQIBLYMHDX-UHFFFAOYSA-N 0.000 description 1
- JNHAYTMSFWSOHN-UHFFFAOYSA-N bis(trifluoromethylsulfonyl)azanide;3-methyl-1-propylpyridin-1-ium Chemical compound CCC[N+]1=CC=CC(C)=C1.FC(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)F JNHAYTMSFWSOHN-UHFFFAOYSA-N 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 150000007516 brønsted-lowry acids Chemical class 0.000 description 1
- 150000007528 brønsted-lowry bases Chemical class 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UNYSKUBLZGJSLV-UHFFFAOYSA-L calcium;1,3,5,2,4,6$l^{2}-trioxadisilaluminane 2,4-dioxide;dihydroxide;hexahydrate Chemical compound O.O.O.O.O.O.[OH-].[OH-].[Ca+2].O=[Si]1O[Al]O[Si](=O)O1.O=[Si]1O[Al]O[Si](=O)O1 UNYSKUBLZGJSLV-UHFFFAOYSA-L 0.000 description 1
- ILOKQJWLMPPMQU-UHFFFAOYSA-N calcium;oxido(oxo)borane Chemical compound [Ca+2].[O-]B=O.[O-]B=O ILOKQJWLMPPMQU-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 229960000228 cetalkonium chloride Drugs 0.000 description 1
- SXPWTBGAZSPLHA-UHFFFAOYSA-M cetalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SXPWTBGAZSPLHA-UHFFFAOYSA-M 0.000 description 1
- 229960002798 cetrimide Drugs 0.000 description 1
- 229960003431 cetrimonium Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- NFCRBQADEGXVDL-UHFFFAOYSA-M cetylpyridinium chloride monohydrate Chemical compound O.[Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NFCRBQADEGXVDL-UHFFFAOYSA-M 0.000 description 1
- RLGQACBPNDBWTB-UHFFFAOYSA-N cetyltrimethylammonium ion Chemical compound CCCCCCCCCCCCCCCC[N+](C)(C)C RLGQACBPNDBWTB-UHFFFAOYSA-N 0.000 description 1
- 229910052676 chabazite Inorganic materials 0.000 description 1
- 238000010382 chemical cross-linking Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 229910001603 clinoptilolite Inorganic materials 0.000 description 1
- 229910021540 colemanite Inorganic materials 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 150000004696 coordination complex Chemical class 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 229960004670 didecyldimethylammonium chloride Drugs 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- WBFZBNKJVDQAMA-UHFFFAOYSA-D dipotassium;zirconium(4+);pentacarbonate Chemical compound [K+].[K+].[Zr+4].[Zr+4].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O WBFZBNKJVDQAMA-UHFFFAOYSA-D 0.000 description 1
- CDMADVZSLOHIFP-UHFFFAOYSA-N disodium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane;decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].O1B([O-])OB2OB([O-])OB1O2 CDMADVZSLOHIFP-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 229960001859 domiphen bromide Drugs 0.000 description 1
- QYDYPVFESGNLHU-UHFFFAOYSA-N elaidic acid methyl ester Natural products CCCCCCCCC=CCCCCCCCC(=O)OC QYDYPVFESGNLHU-UHFFFAOYSA-N 0.000 description 1
- CAMHHLOGFDZBBG-UHFFFAOYSA-N epoxidized methyl oleate Natural products CCCCCCCCC1OC1CCCCCCCC(=O)OC CAMHHLOGFDZBBG-UHFFFAOYSA-N 0.000 description 1
- FARYTWBWLZAXNK-WAYWQWQTSA-N ethyl (z)-3-(methylamino)but-2-enoate Chemical compound CCOC(=O)\C=C(\C)NC FARYTWBWLZAXNK-WAYWQWQTSA-N 0.000 description 1
- 229910052677 heulandite Inorganic materials 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 229940050526 hydroxyethylstarch Drugs 0.000 description 1
- FMXLGOWFNZLJQK-UHFFFAOYSA-N hypochlorous acid;zirconium Chemical compound [Zr].ClO FMXLGOWFNZLJQK-UHFFFAOYSA-N 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 229910003480 inorganic solid Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- NIMLQBUJDJZYEJ-UHFFFAOYSA-N isophorone diisocyanate Chemical compound CC1(C)CC(N=C=O)CC(C)(CN=C=O)C1 NIMLQBUJDJZYEJ-UHFFFAOYSA-N 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 150000007527 lewis bases Chemical class 0.000 description 1
- PGYPOBZJRVSMDS-UHFFFAOYSA-N loperamide hydrochloride Chemical compound Cl.C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)N(C)C)CCN(CC1)CCC1(O)C1=CC=C(Cl)C=C1 PGYPOBZJRVSMDS-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- QYDYPVFESGNLHU-KHPPLWFESA-N methyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC QYDYPVFESGNLHU-KHPPLWFESA-N 0.000 description 1
- 229940073769 methyl oleate Drugs 0.000 description 1
- IZFGRAGOVZCUFB-HJWRWDBZSA-N methyl palmitoleate Chemical compound CCCCCC\C=C/CCCCCCCC(=O)OC IZFGRAGOVZCUFB-HJWRWDBZSA-N 0.000 description 1
- OUAUEIYYLHUEPK-UHFFFAOYSA-M methyl sulfate;1,2,3-trimethylimidazol-1-ium Chemical compound COS([O-])(=O)=O.CC=1N(C)C=C[N+]=1C OUAUEIYYLHUEPK-UHFFFAOYSA-M 0.000 description 1
- 229960002285 methylbenzethonium chloride Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229910052674 natrolite Inorganic materials 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- KBJMLQFLOWQJNF-UHFFFAOYSA-N nickel(II) nitrate Inorganic materials [Ni+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O KBJMLQFLOWQJNF-UHFFFAOYSA-N 0.000 description 1
- UJVRJBAUJYZFIX-UHFFFAOYSA-N nitric acid;oxozirconium Chemical compound [Zr]=O.O[N+]([O-])=O.O[N+]([O-])=O UJVRJBAUJYZFIX-UHFFFAOYSA-N 0.000 description 1
- ZWRUINPWMLAQRD-UHFFFAOYSA-N nonan-1-ol Chemical compound CCCCCCCCCO ZWRUINPWMLAQRD-UHFFFAOYSA-N 0.000 description 1
- CNNRPFQICPFDPO-UHFFFAOYSA-N octacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCO CNNRPFQICPFDPO-UHFFFAOYSA-N 0.000 description 1
- VRQWWCJWSIOWHG-UHFFFAOYSA-J octadecanoate;zirconium(4+) Chemical compound [Zr+4].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O VRQWWCJWSIOWHG-UHFFFAOYSA-J 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- BPYXFMVJXTUYRV-UHFFFAOYSA-J octanoate;zirconium(4+) Chemical compound [Zr+4].CCCCCCCC([O-])=O.CCCCCCCC([O-])=O.CCCCCCCC([O-])=O.CCCCCCCC([O-])=O BPYXFMVJXTUYRV-UHFFFAOYSA-J 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 229940067739 octyl sulfate Drugs 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- CMOAHYOGLLEOGO-UHFFFAOYSA-N oxozirconium;dihydrochloride Chemical compound Cl.Cl.[Zr]=O CMOAHYOGLLEOGO-UHFFFAOYSA-N 0.000 description 1
- LYTNHSCLZRMKON-UHFFFAOYSA-L oxygen(2-);zirconium(4+);diacetate Chemical compound [O-2].[Zr+4].CC([O-])=O.CC([O-])=O LYTNHSCLZRMKON-UHFFFAOYSA-L 0.000 description 1
- QRTRRDMHGTZPBF-UHFFFAOYSA-L oxygen(2-);zirconium(4+);sulfate Chemical compound [O-2].[Zr+4].[O-]S([O-])(=O)=O QRTRRDMHGTZPBF-UHFFFAOYSA-L 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229910001743 phillipsite Inorganic materials 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- JVUYWILPYBCNNG-UHFFFAOYSA-N potassium;oxido(oxo)borane Chemical compound [K+].[O-]B=O JVUYWILPYBCNNG-UHFFFAOYSA-N 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 229940116317 potato starch Drugs 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- TVCBSVKTTHLKQC-UHFFFAOYSA-M propanoate;zirconium(4+) Chemical compound [Zr+4].CCC([O-])=O TVCBSVKTTHLKQC-UHFFFAOYSA-M 0.000 description 1
- 239000000007 protein synthesis inhibitor Substances 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 102220051014 rs141837529 Human genes 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Inorganic materials [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- JRQGFDPXVPTSJU-UHFFFAOYSA-L sodium zirconium(4+) sulfate Chemical compound [Na+].[Zr+4].[O-]S([O-])(=O)=O JRQGFDPXVPTSJU-UHFFFAOYSA-L 0.000 description 1
- IDOPRZMNYMUGCN-UHFFFAOYSA-K sodium;2-hydroxypropane-1,2,3-tricarboxylate;zirconium(4+) Chemical compound [Na+].[Zr+4].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O IDOPRZMNYMUGCN-UHFFFAOYSA-K 0.000 description 1
- JAKYJVJWXKRTSJ-UHFFFAOYSA-N sodium;oxido(oxo)borane;tetrahydrate Chemical compound O.O.O.O.[Na+].[O-]B=O JAKYJVJWXKRTSJ-UHFFFAOYSA-N 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229910052678 stilbite Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- UZZYXUGECOQHPU-UHFFFAOYSA-N sulfuric acid monooctyl ester Natural products CCCCCCCCOS(O)(=O)=O UZZYXUGECOQHPU-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- HWCKGOZZJDHMNC-UHFFFAOYSA-M tetraethylammonium bromide Chemical compound [Br-].CC[N+](CC)(CC)CC HWCKGOZZJDHMNC-UHFFFAOYSA-M 0.000 description 1
- 229940087291 tridecyl alcohol Drugs 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- XZZNDPSIHUTMOC-UHFFFAOYSA-N triphenyl phosphate Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)(=O)OC1=CC=CC=C1 XZZNDPSIHUTMOC-UHFFFAOYSA-N 0.000 description 1
- ASLWPAWFJZFCKF-UHFFFAOYSA-N tris(1,3-dichloropropan-2-yl) phosphate Chemical compound ClCC(CCl)OP(=O)(OC(CCl)CCl)OC(CCl)CCl ASLWPAWFJZFCKF-UHFFFAOYSA-N 0.000 description 1
- HQUQLFOMPYWACS-UHFFFAOYSA-N tris(2-chloroethyl) phosphate Chemical compound ClCCOP(=O)(OCCCl)OCCCl HQUQLFOMPYWACS-UHFFFAOYSA-N 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 235000019263 trisodium citrate Nutrition 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- 229910021539 ulexite Inorganic materials 0.000 description 1
- 229940057402 undecyl alcohol Drugs 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Inorganic materials [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 description 1
- 229910000166 zirconium phosphate Inorganic materials 0.000 description 1
- DUNKXUFBGCUVQW-UHFFFAOYSA-J zirconium tetrachloride Chemical compound Cl[Zr](Cl)(Cl)Cl DUNKXUFBGCUVQW-UHFFFAOYSA-J 0.000 description 1
- XJUNLJFOHNHSAR-UHFFFAOYSA-J zirconium(4+);dicarbonate Chemical compound [Zr+4].[O-]C([O-])=O.[O-]C([O-])=O XJUNLJFOHNHSAR-UHFFFAOYSA-J 0.000 description 1
- ZXAUZSQITFJWPS-UHFFFAOYSA-J zirconium(4+);disulfate Chemical compound [Zr+4].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O ZXAUZSQITFJWPS-UHFFFAOYSA-J 0.000 description 1
- OEERILNPOAIBKF-UHFFFAOYSA-J zirconium(4+);tetraformate Chemical compound [Zr+4].[O-]C=O.[O-]C=O.[O-]C=O.[O-]C=O OEERILNPOAIBKF-UHFFFAOYSA-J 0.000 description 1
- LEHFSLREWWMLPU-UHFFFAOYSA-B zirconium(4+);tetraphosphate Chemical compound [Zr+4].[Zr+4].[Zr+4].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LEHFSLREWWMLPU-UHFFFAOYSA-B 0.000 description 1
- LSWWNKUULMMMIL-UHFFFAOYSA-J zirconium(iv) bromide Chemical compound Br[Zr](Br)(Br)Br LSWWNKUULMMMIL-UHFFFAOYSA-J 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K5/00—Heat-transfer, heat-exchange or heat-storage materials, e.g. refrigerants; Materials for the production of heat or cold by chemical reactions other than by combustion
- C09K5/02—Materials undergoing a change of physical state when used
- C09K5/06—Materials undergoing a change of physical state when used the change of state being from liquid to solid or vice versa
- C09K5/063—Materials absorbing or liberating heat during crystallisation; Heat storage materials
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K5/00—Heat-transfer, heat-exchange or heat-storage materials, e.g. refrigerants; Materials for the production of heat or cold by chemical reactions other than by combustion
- C09K5/08—Materials not undergoing a change of physical state when used
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/02—Monosaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/12—Disaccharides
Definitions
- the present disclosure relates to methods of making thermal energy storage or phase change material (PCM) compositions.
- PCM phase change material
- Latent heat includes thermal energy released or absorbed during a change of state of a material without a change or substantial change in the temperature of the material.
- the change of state can include a phase change such as a solid-liquid, solid-gas, liquid-gas, or solidsolid phase change, including a crystalline solid to amorphous solid phase change or other solid- to-solid phase change.
- phase change materials PCMs
- PCMs phase change materials
- the use of PCMs has been limited in some instances by disadvantages associated with the thermal energy storage capacity and/or form of certain PCMs. For example, some materials suffer from large volume changes and/or flow in a liquid state. Improved compositions are therefore desired for thermal energy storage and other applications.
- compositions and methods of making compositions for thermal energy storage are contemplated herein which, in some embodiments, may offer one or more advantages over prior compositions and methods.
- a composition described herein exhibits a high latent heat during a solid-to-solid or shape-stable transition, thereby providing a composition that is useful in various applications in which shape stability and/or elimination of flow in the “melted” phase is relevant.
- Such applications can include thermal energy storage and temperature control applications.
- a composition described herein comprises 0.5-10 wt. % polysaccharide or polysaccharide component, and 88-99.5 wt. % water, wherein the weight percentages are based on the total weight of the composition.
- the composition is shape stable at 20°C and 1 atm for at least 24 hours or for a longer time period, as described further below.
- the composition has a dynamic viscosity of greater than or equal to 300,000 cP at 20°C and 1 atm.
- the polysaccharide of a composition described herein comprises a cellulose, cellulose ether, starch, seaweed gum or seaweed hydrocolloid (such as an alginate or alginic acid, an agar, or a carrageenan), chitosan, gum Arabic, locust bean gum, guar gum, xanthan gum, or a combination of two or more of the foregoing.
- any of the foregoing polysaccharides can be functionalized or chemically modified, such as by alkoxylation, alkylation, or other functionalization.
- a composition described herein can also comprise or include one or more additional species or components, in addition to water and a polysaccharide.
- a composition described herein further comprises a pH modulator, such an inorganic or organic acid or base.
- the pH modulator lowers the pH of the composition, while in other cases the pH modulator raises the pH of the composition. It is also possible for more than pH modulator to be used.
- a composition described herein further comprises an ionic liquid, a kinetic control agent, a filler (e.g., a solid filler), a fire retardant, a polymeric material (other than or in addition to the polysaccharide), and/or an antimicrobial material.
- a composition described herein further comprises at least one organic PCM.
- a method of forming a shape stable PCM described herein comprises combining a first component and a second component to provide a crosslinking matrix. The method further comprises dispensing the crosslinking matrix into a reaction vessel under conditions whereby the crosslinking matrix crosslinks to form the shape stable phase change material. Moreover, in some cases, the conditions whereby the crosslinking matrix crosslinks to form the shape stable phase change material comprise a period of time between 1 second and 100 hours.
- the crosslinking matrix crosslinks to form the shape stable phase change material in a period of time between 1 second and 1 hour, between 1 second and 30 minutes, between 1 second and 10 minutes, or between 1 second and 5 minutes.
- the first component and/or the second component is, individually, flowable at temperatures above 0°C at 1 atm.
- the shape stable PCM formed by the method is shape stable at temperatures above 0°C at 1 atm.
- combining the first component and the second component to provide the crosslinking matrix comprises combining the first component and the second component in a particular ratio, such as a ratio of the first component to the second component of between about 70:30 and about 90: 10 by volume.
- combining the first component and the second component to provide the crosslinking matrix comprises combining the first component and the second component in a ratio of the first component to the second component of between about 70:30 and about 85: 15 by volume or between about 70:30 and about 80:20 by volume. In other embodiments, combining the first component and the second component to provide the crosslinking matrix comprises combining the first component and the second component in a ratio of the first component to the second component of about 75:25 by volume.
- combining the first component and the second component to provide the crosslinking matrix comprises adding or disposing the first component in a first fluid stream and adding or disposing the second component in a second fluid stream, and the first fluid stream is combined with the second fluid stream.
- combining the first component and the second component to provide the crosslinking matrix comprises directing the first fluid stream and the second fluid stream to intersect in a homogenization chamber.
- the homogenization chamber may be suspended above the reaction vessel, such that dispensing the crosslinking matrix into the reaction vessel comprises gravity feeding the crosslinking matrix from the homogenization chamber to the reaction vessel.
- the first fluid stream is flowed towards the homogenization chamber through a first nozzle
- the second fluid stream is flowed towards the homogenization chamber through a second nozzle.
- the first nozzle has a first diameter
- the second nozzle has a second diameter.
- a ratio of the first diameter to the second diameter corresponds to a volumetric ratio of the first component to the second component, within 10%.
- the ratio of the first diameter to the second diameter is between about 70:30 and about 90: 10, between about 70:30 and about 80:20, or between about 70:30 and 85: 15. In some other instances, the ratio of the first diameter to the second diameter is about 75:25.
- the first component comprises or includes at least a first linker and/or the second component comprises or includes at least a second linker component.
- the first linker component and/or the second linker component when combined with other species present in the first component and/or second component, can crosslink to make the resulting PCM or composition shape stable or substantially shape stable under desired conditions.
- the first linker component and the second linker component are both present, and the two linker components can crosslink to form the shape stable PCM or to provide shape stability to the PCM.
- the first linker component and the second linker component crosslink to form the shape stable phase change material over a period of at least 1 hour at 0°C and 1 atm in the absence of the second component, and over a period of less than 1 hour, less than 30 minutes, less than 15 minutes, or less than 5 minutes at 0°C and 1 atm in the presence of the second component. That is, in some cases, the rate of crosslinking of the first linker component with the second linker component differs, depending on whether the second component is present or absent.
- the first linker component and the second linker component crosslink to form the shape stable phase change material over a period of at least 3 hours at 0°C and 1 atm in the absence of the second component, and over a period of less than 3 hours, less than 2 hours, less than 1 hour, less than 30 minutes, less than 15 minutes, or less than 5 minutes at 0°C and 1 atm in the presence of the second component.
- the first component and/or the second component comprises at least one catalyzing agent operable to increase a rate of crosslinking between the first linker component and the second linker component (or to increase the rate of crosslinking of the first linker component with itself, or of the second linker component with itself).
- the first component and/or the second component comprises at least one pH modulator.
- the first component comprises a first catalyzing agent and/or a first pH modulator
- the second component comprise a second catalyzing agent and/or a second pH modulator.
- the first component comprises a first ionic liquid, a first kinetic control agent, a first filler (e.g., a first solid filler), a first fire retardant, a first polymeric material (other than or in addition to the polysaccharide), a first antimicrobial material, a first organic PCM, or a combination of two or more of the foregoing; and the second component comprises a second ionic liquid, a second kinetic control agent, a second filler (e.g., a second solid filler), a second fire retardant, a second polymeric material (other than or in addition to the polysaccharide), a second antimicrobial material, a second organic PCM, or a combination of two or more of the foregoing.
- a first ionic liquid e.g., a first kinetic control agent
- a first filler e.g., a first solid filler
- a first fire retardant e.g., a first polymeric material (other than or
- Figure l is a schematic representation of a first component flowing toward a second component to be combined in a homogenization chamber to provide a crosslinking matrix to feed downward to a reaction vessel, according to some embodiments described herein.
- Figure 2 is a schematic representation of a first component flowing toward a second component to be combined in a homogenization chamber wherein the diameter of the first nozzle is larger than that of the diameter of the second nozzle, according to some embodiments described herein.
- the phrase “up to” is used in connection with an amount or quantity, it is to be understood that the amount is at least a detectable amount or quantity.
- a material present in an amount “up to” a specified amount can be present from a detectable amount and up to and including the specified amount.
- the terms “substantially,” “approximately,” and “about” may be substituted with “within [a percentage] of’ what is specified, where the percentage could be 0.1, 1, 5, or 10 percent, unless the use of such a term in a given instance indicates otherwise.
- such a method comprises combining a first component and a second component to provide a crosslinking matrix and dispensing the crosslinking matrix into a reaction vessel under conditions whereby the crosslinking matrix crosslinks to form the shape stable phase change material.
- these conditions comprise a specified time period, a specified temperature, and/or a specified temperature.
- the conditions comprise a period of time between 1 second and 100 hours, between 1 second and 1 hour, between 1 second and 30 minutes, between 1 second and 10 minutes, or between 1 second and 5 minutes.
- the time period can also be a time period within a subrange of the foregoing ranges.
- the conditions comprise a pressure between 0.9 and 1.1 atm. Additionally, in some instances, the conditions comprise a temperature between 20°C and 80°C, between 20°C and 70°C, between 20°C and 60°C, between 20°C and 50°C, between 20°C and 40°C, between 20°C and 35°C, between 20°C and 30°C, between 25°C and 70°C, between 25°C and 60°C, between 25°C and 50°C, between 25°C and 40°C, or between 25°C and 35°C.
- the first component and/or the second component is flowable at temperatures above 0°C at 1 atm.
- the first component and/or the second component is predominantly aqueous (e.g., the formed shape stable PCM contains at least 88% water).
- the first component and/or the second component is stable at temperatures above 0°C at 1 atm.
- the first component and/or the second component may form no visually observable paste or gel over a specified period of time.
- a stable component e.g., a “stable” first component and/or a “stable” second component
- the first component and/or the second component is stable (e.g., no change or less than 10% or 5% change in dynamic viscosity and/or no visually observable paste or gel formation) at 1 atm at a temperature above 0°C (e.g., at a temperature of 15-30°C) for 1 week, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 7 months, 8 months, 9 months, 10 months, 11 months, 1 year, 15 months, 18 months, 21 months, or 2 years.
- both the first component and the second component are stable at temperatures above 0°C at 1 atm for 1 week, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 7 months, 8 months, 9 months, 10 months, 11 months, 1 year, 15 months, 18 months, 21 months, or 2 years.
- Methods described herein comprise combining a first component and a second component to provide a crosslinking matrix.
- Any first component and/or second component may be used consistent with the present disclosure, as described further hereinbelow.
- the first component comprises at least a first linker component or a plurality of linker components.
- a first component comprises or includes a first linker component and comprises or includes a second linker component.
- the first and second linker components when combined, crosslink to make the resulting phase change material or composition shape stable or substantially shape stable under desired conditions.
- a composition described herein exhibits a high latent heat during a solid-to-solid or shape-stable transition, thereby providing a composition that is useful in various applications in which shape stability and/or elimination of flow in the “melted” phase are relevant.
- Such applications can include thermal energy storage and temperature control applications.
- such a composition is self-supporting or shape stable, including at ambient or other moderate temperature and pressure.
- a composition is shape stable (including without support by side walls or a container or the like) at temperatures above 0°C at 1 atm, such as at one or more temperatures selected from Table 1 below.
- the composition is shape stable at 20°C and 1 atm.
- the relative humidity may be 50%.
- Such a shape stable composition in some implementations, does not deform or flow substantially under these conditions for more than 1 hour, more than 2 hours, more than 5 hours, or more than 12 hours.
- the composition is solid or is shape-stable and does not flow or deform for 1-24 hours, 1-12 hours, 2-18 hours, or 2-6 hours under the conditions described above.
- a composition made by a method described herein may have some fluidity, such as may be exhibited by a paste or gel.
- a composition described herein has a dynamic viscosity of greater than or equal to 300,000 cP at 20°C and 1 atm.
- a composition made by a method described herein may also comprise a network, such as a crosslinked polysaccharide network or other network.
- a composition made by a method described herein comprises a polysaccharide network (or other network) including many hydrogen bonds with water. Additionally, not intending to be bound by theory, the water may form a continuous phase within a scaffolding formed by the polysaccharide (or other material).
- compositions described herein can have any pH not inconsistent with the objectives of the present disclosure.
- a composition described herein can have a pH of between about 2 and about 12, such as between about 2 and about 7, between about 7 and about 12, between about 5 and about 7, between about between about 3 and about 7, between about 4 and about 7, between about 5 and about 7, or between about 6 and about 7.
- a pH of a composition described herein can be between about 7 and about 12, between about 8 and about 12, between about 8 and about 12, between about 9 and about 12, between about 10 and about 12, or between about 11 and about 12.
- a composition described herein may have a pH of between about 7 and about 11, between about 7 and about 10, between about 7 and about 9, or between about 7 and about 8.
- a composition described herein may have a pH between about 5 and about 9, such as between about 5 and about 8, between about 6 and about 9, or between about 6 and about 8, between about 6 and about 7, or between about 7 and about 8.
- a pH between about 5 and about 9, such as between about 5 and about 8, between about 6 and about 9, or between about 6 and about 8, between about 6 and about 7, or between about 7 and about 8.
- the use of one or more pH modulators can permit a composition described herein to be prepared and/or used across a variety of pH ranges.
- first component and second component may be combined in any ratio consistent with the objectives of the present disclosure.
- a ratio (by volume) of the first component to the second component in the crosslinking matrix is between about 50:50 and about 90: 10, such as between about 60:40 and about 90: 10, between about 70:30 and 90: 10, or between about 70:30 and 80:20.
- the ratio in the crosslinking matrix may also be about 75:25 by volume.
- combining the first component and the second component to provide the crosslinking matrix comprises combining the first component and the second component in a ratio of the first component to the second component of between about 70:30 and about 90:10 by volume, between about 70:30 and about 85: 15 by volume, between about 70:30 and about 80:20 by volume, or in a ratio of about 75:25 by volume.
- Combining the first component and the second component to provide the first crosslinking matrix can be carried out in any manner not inconsistent with the objectives of the present disclosure.
- combining the first component and the second component to provide the crosslinking matrix comprises adding or disposing the first component in a first fluid stream and adding or disposing the second component in a second fluid stream.
- a method (100) comprises directing the first fluid stream (101) and the second fluid stream (102) to intersect in a homogenization chamber (103) to provide the crosslinking matrix (104), and dispensing the crosslinking matrix into the reaction vessel (105) comprises gravity feeding or otherwise free-flowing the crosslinking matrix from the homogenization chamber to the reaction vessel (105), as indicated by the arrow in Figure 1.
- the turbulence caused by flowing the streams towards one another causes the mixing or homogenization without further agitation.
- complete or substantially complete homogenization of the first and second components occurs in-line (e.g., within the homogenization chamber and before leaving the homogenization chamber).
- homogenization may also occur within a short period of time (e.g., in 10 seconds or less, 5 seconds or less, 3 seconds or less, or less than 1 second). Homogenizing the first and second components in a manner described herein, in some cases, can reduce or prevent clogging of the manufacturing equipment, which may otherwise occur due to crosslinking of the components in situ.
- Combining the first component and the second component to provide the first crosslinking matrix can be carried out at any temperature not inconsistent with the objectives of the present invention.
- combining the first component and the second component is carried out at a temperature of 0°C-50°C, 0°C-40°C, 0°C-30°C, 0°C-20°C, 0°C- 10°C, 10°C-50°C, 10°C-40°C, 10°C-30°C, 10°C-20°C, 20°C-50°C, 20°C-40°C, 20°C-30°C, 30°C-50°C, 30°C-40°C, or 40°C-50°C at 1 atm.
- directing and/or flowing the first component and the second component toward one another may be controlled volumetrically. Not intending to be bound by theory, it is believed that such volumetric control can maintain or substantially maintain a ratio of the first component to the second component upon entering the homogenization chamber.
- this volumetric control may be implemented by flowing the first component through a first nozzle having a first nozzle diameter and flowing the second component through a second nozzle having a second nozzle diameter (e.g., at the same applied force).
- the first and second nozzle diameters may be sized, as by diameter, to have a specific ratio relative to one another.
- a ratio of the first diameter to the second diameter is between about 50:50 and about 90:10, such as between about 60:40 and about 90: 10, between about 70:30 and about 90: 10, or between about 70:30 and about 80:20. Further, in some embodiments, the ratio of the first diameter to the second diameter is about 75:25. In some cases, the ratio of the first diameter to the second diameter corresponds to a volumetric ratio of the first component to the second component, within 10%.
- a non-limiting example embodiment (200) of such a method is shown in Figure 2.
- a first component (201) flows through a first nozzle (202) having a first nozzle diameter toward the homogenization chamber (203).
- a second component (204) flows through a second nozzle (205) having a second nozzle diameter toward the homogenization chamber (203).
- the diameter of the first nozzle is larger than that of the diameter of the second nozzle.
- the first component and second component combine in the homogenization chamber to provide the crosslinking matrix (206).
- Dispensing the crosslinking matrix into the reaction vessel (207) comprises gravity feeding or otherwise free-flowing the crosslinking matrix from the homogenization chamber to the reaction vessel (207).
- the homogenization chamber may be a T-connector, permitting fluid flow from opposing sides of the connector with a third opening for releasing the crosslinking matrix from the homogenization chamber.
- a first fluid stream comprising the first component can enter a first side of the T-connector and a second fluid stream comprising the second component can enter a second, opposing side of the T-connector.
- the homogenization chamber is suspended above a reaction vessel.
- dispensing the crosslinking matrix into the reaction vessel comprises gravity feeding or otherwise free-flowing the crosslinking matrix from the homogenization chamber to the reaction vessel.
- a homogenization chamber may also be at any temperature not inconsistent with the objectives of the present invention.
- a homogenization chamber may be between 0°C-50°C, between 0°C-40°C, between 0°C-30°C, between 0°C-20°C, between 0°C- 10°C, between 10°C-50°C, between 10°C-40°C, between 10°C-30°C, between 10°C-20°C, between 20°C-50°C, between 20°C-40°C, between 20°C-30°C, between 30°C-50°C, between 30°C-40°C, or between 40°C-50°C at 1 atm.
- the first component comprises at least a first linker component and at least a second linker component which can crosslink to form the shape stable phase change material.
- a linker component may also be referred to herein as a “crosslinker component” or a “crosslinker.”
- crosslinking can comprise chemical crosslinking, such as may be achieved by the formation of one or more covalent bonds, one or more hydrogen bonds, or one or more other bonds having sufficient bond strength or binding energy to form a crosslinked network, which may be chemically and/or physically stable in an aqueous environment for at least 1 day, at least 3 days, at least 5 days, at least 7 days, at least 10 days, at least 1 month, at least 6 months, or at least 1 year.
- Such an aqueous environment may have a pH of 4-10 or 6-8, a temperature of -20°C to 50°C, and a pressure of 0.7-1.3 atm
- a first component comprises at least a first linker component and at least a second linker component, and the first linker component and the second linker component crosslink to form the shape stable phase change material over a relatively short period of time when mixed or combined with the second component of a method described herein, but crosslink over a relatively long period of time (or not at all) in the absence of the second component.
- the first linker component and the second linker component crosslink to form the shape stable phase change material over a period of at least 1 hour at 0°C and 1 atm in the absence of the second component, and over a period of less than 1 hour, less than 30 minutes, less than 15 minutes, or less than 5 minutes at 0°C and 1 atm in the presence of the second component.
- the first linker component and the second linker component crosslink to form the shape stable phase change material over a period of at least 3 hours at 0°C and 1 atm in the absence of the second component, and over a period of less than 3 hours, less than 2 hours, less than 1 hour, less than 30 minutes, less than 15 minutes, or less than 5 minutes at 0°C and 1 atm in the presence of the second component.
- the second component comprises at least one catalyzing agent operable to increase a rate of crosslinking between the first linker component and the second linker component. Any catalyzing agent not inconsistent with the objectives of the present disclosure may be used.
- the catalyzing agent comprises a metal or metal complex or metal compound such as a transition metal or transition metal complex or compound, an enzyme, a non-enzyme organocatalyst, a Lewis acid, a Lewis base, a Bronsted-Lowry acid, or a Bronsted- Lowry base.
- a catalyzing agent described herein may be a true catalyst in the sense the catalyzing agent is not itself consumed as a reagent (e.g., stoichiometrically), or a catalyzing agent may be a reactant that is itself consumed and not necessarily regenerated by the crosslinking reaction or in a reaction step prior to the crosslinking reaction.
- a linker component described herein in some embodiments, can link or form a network with one or more other components used to make a composition described herein.
- a linker component is chemically bonded to another component of the composition, such as a polysaccharide described herein, which may be described herein as a “linked component.”
- the “linked component” it is also possible for the “linked component” to itself be a linker component described herein, such that the linker component is crosslinked with itself or with a different linker component.
- a first linker component can crosslink with a second linker component to form a network or to form a shape stable phase change material.
- a linker component chemically bonded to such a linked component provides a non-polymeric material.
- a linker component chemically bonded to a linked component provides an oligomeric material.
- a linked component is monofunctional.
- a monofunctional linked component in some embodiments, can be chemically bonded to a linker component through a single functional group, such as a carboxyl or hydroxyl group.
- the linker component is polyfunctional.
- a polyfunctional crosslinker in some embodiments, can be chemically bonded to more than one linked component, including more than one monofunctional linked component.
- a bifunctional crosslinker can be chemically bonded to two monofunctional linked components (A) to provide an A-B-A trimer.
- a bifunctional crosslinker is chemically bonded to one monofunctional linked component to provide an A-B dimer.
- the crosslinker can be chemically bonded to a linked component through any chemical bond not inconsistent with the objectives of the present invention.
- a linker component is chemically bonded to a linked component through a covalent bond.
- the crosslinker is chemically bonded to a linked component through an ionic bond or electrostatic bond.
- the crosslinker is chemically bonded to a linked component through a hydrogen bond.
- the crosslinker is chemically bonded to a linked component through a urethane bond.
- the crosslinker is chemically bonded to a linked component through an amide bond.
- the crosslinker is chemically bonded to a linked component through an ester bond.
- the crosslinker described herein can comprise any chemical species not inconsistent with the objectives of the present disclosure.
- the crosslinker comprises a functional group capable of forming a covalent bond with a functional group of a linked component described herein, such as a carboxyl group or a hydroxyl group.
- the crosslinker comprises a polyol.
- the crosslinker comprises a saccharide, including a monosaccharide, disaccharide, oligosaccharide, or polysaccharide.
- the polysaccharide of a composition described herein comprises a cellulose, a cellulose derivative, cellulose ether, starch, seaweed gum or seaweed hydrocolloid (such as an alginate or alginic acid, an agar, or a carrageenan), chitosan, gum Arabic, locust bean gum, guar gum, xanthan gum, galactomannan polysaccharide, or a combination of two or more of the foregoing.
- any of the foregoing polysaccharides can be functionalized or chemically modified, such as by alkoxylation, alkylation, or other functionalization, e.g., to provide a cellulose ether.
- the polysaccharide comprises a hydroxyethyl starch, hydroxyethyl polysaccharide, or hydroxy ethylcellulose. In some instances, the polysaccharide comprises a potato starch, corn starch, rice starch, or wheat starch.
- a composition (or a first component and/or second component) can comprise or include a carboxymethyl ether of one or more polysaccharides.
- a composition (or a first component and/or second component) described herein comprises or includes a carboxymethyl ether formed or derived from one or more of the following: cellulose, chitin, chitosan, curdlan, dextran, pullulan , schleroglucan, schizophyllan, starch, amylase, amylopectin, seaweed gum or seaweed hydrocolloid (such as an alginate or alginic acid, an agar, or a carrageenan), gum Arabic, locust bean gum , guar gum, or xanthan gum, or a combination of two or more of the foregoing.
- Carboxymethyl ethers may also be formed from natural, synthetic, or functionalized polysaccharides.
- Compositions (or a first component and/or second component) described herein may comprise of combinations of carboxymethyl ethers wherein each carboxymethyl ether is derived from a separate member of the foregoing group of polysaccharides.
- compositions (or a first component and/or second component) described herein may comprise or include one or more salts of a carboxymethyl ether.
- a composition (or a first component and/or second component) described herein comprises sodium starch glycolate.
- a polysaccharide (or related species) described herein can have any molecular weight not inconsistent with the objectives of the present disclosure.
- a polysaccharide has a weight average molecular weight between about 2,000 and about 3,000,000, between about 20,000 and 2,500,000, or between about 100,000 and about 2,000,000.
- a polysaccharide is present in a composition or crosslinking matrix described herein in an amount of about 0.5-7 wt. % or in an amount of about 1-5 wt. %, based on the total weight of the composition or crosslinking matrix.
- a composition or crosslinking matrix comprising a polysaccharide is not a solution or colloid of the polysaccharide.
- water is present in the composition or crosslinking matrix in amount of 90-99 wt.% or in an amount of 95-99.5 wt. %, based on the total weight of the composition or crosslinking matrix.
- the crosslinker comprises a sugar alcohol, such as glycol, glycerol, erythritol, threitol, arabitol, xylitol, ribitol, mannitol, sorbitol, dulcitol, iditol, isomalt, maltitol, or lactitol.
- a sugar alcohol such as glycol, glycerol, erythritol, threitol, arabitol, xylitol, ribitol, mannitol, sorbitol, dulcitol, iditol, isomalt, maltitol, or lactitol.
- the crosslinker or linker component comprises an isocyanate.
- a linker component comprises a diisocyanate, such as a methylene diphenyl diisocyanate (MDI), toluene diisocyanate (TDI), naphthalene diisocyanate (NDI), isophorone diisocyanate (IPDI), and/or hexamethylene diisocyanate (HDI).
- MDI methylene diphenyl diisocyanate
- TDI toluene diisocyanate
- NDI naphthalene diisocyanate
- IPDI isophorone diisocyanate
- HDI hexamethylene diisocyanate
- Non-limiting examples of diisocyanates suitable for use in some embodiments described herein include Lupranate® LP27, LP30, LP30D, M, MI, MS, MIO, M20, M20S, M20FB, M20HB, M20SB, M70L, MM103, MP102, MS, R2500, R2500U, T80-Type 1, T80-Type 2, TF2115, 78, 81, 219, 223, 227, 230, 234, 245, 259, 265, 266, 273, 275, 278, 280, 281, 5010, 5020, 5030, 5040, 5050, 5060, 5070, 5080, 5090, 5100, 5110, 5140, 5143, and 8020, which are all commercially available from BASF.
- diisocyanates suitable for use in some embodiments described herein include Suprasec® 2004, 2029, 5025, 7316, 7507, 9150, 9561, 9577, 9582, 9600, 9603, 9608, 9612, 9610, 9612, 9615, and 9616 as well as Rubinate® 1209, 1234, 1670, 1790, 1920, 9040, 9234, 9236, 9271, 9272, 9465, and 9511, which are all commercially available from Huntsman.
- Other major producers of diisocyanates include Bayer, BorsodChem, Dow, Mitsui, Nippon Polyurethane Industry and Yantai Wanhua.
- a composition described herein comprises a plurality of crosslinkers or linker components. Any combination of crosslinkers not inconsistent with the objectives of the present invention may be used.
- a first and/or second linker component or crosslinker described herein can be present in a composition or in a component (e.g., in a first or second component) in any amount not inconsistent with the objectives of the present disclosure.
- a component comprises less than about 10 weight percent of the crosslinker based on the total weight of the component.
- a component e.g., a first or second component described herein
- a component e.g., a first or second component described herein
- a composition comprises between about 1 weight percent and about 5 weight percent of the crosslinker or between about 1 weight percent about 8 weight percent crosslinker.
- a composition or a first component and/or second component described herein further comprises an ionic liquid. Any ionic liquid not inconsistent with the objectives of the present disclosure may be used.
- an ionic liquid is pyridinium-based.
- the ionic liquid comprises a sugar or sugar alcohol.
- Non-limiting examples of ionic liquids which may be used in some embodiments described herein include l-Allyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide, 1-Allyl- 3-methylimidazolium bromide, l-Allyl-3-methylimidazolium dicyanamide, l-Allyl-3- methylimidazolium iodide, l-Benzyl-3-methylimidazolium chloride, l-Benzyl-3- methylimidazolium hexafluorophosphate, l-Benzyl-3-methylimidazolium tetrafluoroborate, 1,3- Bis(3-cyanopropyl)imidazolium bi s(trifluorom ethyl sulfonyl)imide, 1,3-Bis(3- cyanopropyl)imidazolium chloride, l-Butyl-2,3-dimethylimida
- one or more of the pH modulators may comprise or include an ionic liquid.
- An ionic liquid can be present in a first component and/or second component described herein in any amount not inconsistent with the technical objectives of the present disclosure.
- a first component and/or a second component comprises up to 10 wt. %, up to 7 wt. %, up to 5 wt. %, up to 2 wt. %, or up to 1 wt. % ionic liquid, based on the total weight of the first component and/or the second component, respectively.
- a first component and/or a second component comprises 0.5-10 wt. %, 1-10 wt.
- a composition (or a first component and/or second component) described herein further comprises a kinetic control agent.
- a kinetic control agent in some cases, can increase or decrease the rate of formation of a shape stable PCM described herein. Any kinetic control agent not inconsistent with the technical objectives of the present disclosure may be used.
- a kinetic control agent comprises a zirconium compound, complex, or salt.
- a kinetic control agent comprises a zirconium halide or related species, such as zirconium oxychloride, zirconium hydroxychloride, zirconium tetrachloride, zirconium bromide, or a combination of two or more of the foregoing.
- a kinetic control agent comprises a zirconium salt of a mineral acid, such as zirconium sulfate, basic zirconium sulfate, zirconium oxynitrate, zirconium oxy acetate, zirconium oxycarbonate, or a combination of two or more of the foregoing.
- a kinetic control agent comprises a zirconium salt of an organic acid, such as zirconium formate, zirconium acetate, zirconium propionate, zirconium caprylate, zirconium stearate, zirconium lactate, zirconium nitrate, zirconium carbonate, zirconium octylate, zirconium citrate, zirconium phosphate, or a combination of two or more of the foregoing.
- an organic acid such as zirconium formate, zirconium acetate, zirconium propionate, zirconium caprylate, zirconium stearate, zirconium lactate, zirconium nitrate, zirconium carbonate, zirconium octylate, zirconium citrate, zirconium phosphate, or a combination of two or more of the foregoing.
- a kinetic control agent described herein comprises a complex salt such as ammonium zirconium carbonate, ammonium zirconium phosphate, ammonium zirconium sulfate, ammonium zirconium oxalate, ammonium zirconium acetate, ammonium zirconium citrate, ammonium zirconium lactate, potassium zirconium carbonate, sodium zirconium sulfate, sodium zirconium oxalate, sodium zirconium citrate, or a combination of two or more of the foregoing.
- a complex salt such as ammonium zirconium carbonate, ammonium zirconium phosphate, ammonium zirconium sulfate, ammonium zirconium oxalate, ammonium zirconium acetate, ammonium zirconium citrate, ammonium zirconium lactate, potassium zirconium carbonate, sodium zirconium sulfate, sodium zir
- a kinetic control agent described herein comprises boric acid or a borate.
- a kinetic control agent described herein comprises boric acid, calcium metaborate, kodalk or sodium metaborate, potassium metaborate, dipotassium tetraborate, sodium tetraborate, sodium metaborate tetrahydrate, sodium tetraborate decahydrate, or a combination of two or more of the foregoing.
- a kinetic control agent comprises a borate ore or mineral (e.g., in alkaline solution).
- a kinetic control agent comprises ulexite, raphite, nobleite (Nobleite), Gowerite, hydroborocalcite (Frolovite), colemanite, meyerhoffite, inyoite, pandermite, tertschite, ginorite (Ginorite), pinnoite, paternoite (Patemoite), kurnakovite (Kurnakovite), inderite, Preobazhenskite, hydroboracite (Hydroboracite), inderborite (Inderborite), heintzite (Heintzite) Vealchite, or a combination of two or more of the foregoing.
- a kinetic control agent when used, can be present in a first component and/or second component described herein in any amount not inconsistent with the technical objectives of the present disclosure.
- a first component and/or a second component comprises up to 10 wt. %, up to 7 wt. %, up to 5 wt. %, up to 2 wt. %, or up to 1 wt. % kinetic control agent, based on the total weight of the first component and/or the second component, respectively.
- a first component and/or a second component comprises 0.5-10 wt. %, 1-10 wt. %, 1-7 wt. %, 1-5 wt.
- % 2-10 wt. %, 2-7 wt. %, 2-5 wt. %, 3-10 wt. %, 3- 7 wt. %, 3-5 wt. %, 5-10 wt. %, or 5-7 wt. % kinetic control agent, based on the total weight of the first component and/or the second component, respectively.
- a composition (or a first component and/or second component) described herein further comprises a filler (e.g., a solid filler).
- a filler e.g., a solid filler.
- a filler comprises an inorganic material, such as an inorganic solid.
- a filler comprises SiCh, ZrCh, or TiCh.
- a filler comprises CaO or MgO.
- a filler when used, can be present in a first component and/or second component described herein in any amount not inconsistent with the technical objectives of the present disclosure.
- a first component and/or a second component comprises up to 10 wt. %, up to 7 wt. %, up to 5 wt. %, up to 2 wt. %, or up to 1 wt. % filler, based on the total weight of the first component and/or the second component, respectively.
- a first component and/or a second component comprises 0.5-10 wt. %, 1-10 wt. %, 1-7 wt. %, 1-5 wt. %, 2-10 wt.
- the first component and/or the second component further comprises a fire retardant.
- a fire retardant comprises a foam.
- a fire retardant can comprise an organic composition or an inorganic composition.
- a fire retardant comprises a phosphate, such as ammonium phosphate, trisodium phosphate, triphenyl phosphate, tricresylphosphate, tris(2-chloroethyl)phosphate, tris(2-chloro-l-(chloromethyl)ethyl)phosphate, tris(chloropropyl)phosphate, tris(l,3-dichloro-2- propyl (phosphate, or tetrekis(2-chlorethyl)dichloroisopentyldiphosphate.
- a fire retardant comprises aluminum hydroxide and/or magnesium hydroxide.
- a fire retardant may also comprise a zeolite. Any zeolite not inconsistent with the objectives of the present disclosure may be used.
- a zeolite comprises a natural zeolite.
- a zeolite comprises an artificial zeolite.
- a zeolite comprises a silicate and/or aluminosilicate.
- a zeolite comprises a composition according to the formula Mv/ Struktur [(AlCh SiChj l • vi’HiO, where n is the valence of cation M (e.g., Na + , K + , Ca 2+ , or Mg 2+ ), w is the number of water molecules per unit cell, and x and j are the total number of tetrahedral atoms per unit cell.
- Non-limiting examples of zeolites suitable for use in some embodiments described herein include analcime ((K,Ca,Na)AlSi2Oe • H2O), chabazite ((Ca,Na2,K2,Mg)AhSi40i2 • 6H2O), clinoptilolite ((Na,K,Ca)2-3 Ah(Al, Si)2Si 13O36 • I2H2O), heulandite ((Ca,Na)2-3A13(Al,Si)2Sii3O36 • I2H2O), natrolite (Na2AhSi30io • 2H 2 O), phillipsite ((Ca,Na2,K2) 3 Al 6 Siio032 • 12H 2 O), and stilbite (NaCa 4 (Si 2 7A19)O72 • 28H 2 O).
- analcime ((K,Ca,Na)AlSi2Oe
- a fire retardant when used, can be present in a first component and/or second component described herein in any amount not inconsistent with the technical objectives of the present disclosure.
- a first component and/or a second component comprises up to 10 wt. %, up to 7 wt. %, up to 5 wt. %, up to 2 wt. %, or up to 1 wt. % fire retardant, based on the total weight of the first component and/or the second component, respectively.
- a first component and/or a second component comprises 0.5-10 wt. %, 1-10 wt. %, 1-7 wt. %, 1-5 wt.
- a composition (or a first component and/or second component) described herein may also comprise a polymeric material (other than or different from a polysaccharide component described herein). Any polymeric material not inconsistent with the objectives of the present disclosure may be used.
- a polymeric material comprises an organic composition.
- a polymeric material comprises a polyolefin such as polyethylene or polypropylene, a polycarbonate, a polyester, or a polyurethane.
- a polymeric material comprises polyvinyl alcohol (PVA).
- a polymeric material comprises an acrylic acid-based polymer.
- an acrylic acid-based polymer described herein comprises poly(acrylic acid) (PAA) and/or an acrylic acid based copolymer.
- a first component and/or a second component comprises up to 10 wt. %, up to 7 wt. %, up to 5 wt. %, up to 2 wt. %, or up to 1 wt. % polymeric material, based on the total weight of the first component and/or the second component, respectively.
- a first component and/or a second component comprises 0.5-10 wt. %, 1-10 wt. %, 1-7 wt. %, 1-5 wt.
- the first component and/or the second component further comprises an antimicrobial material.
- An antimicrobial material comprises an inorganic composition, including metals and/or metal salts.
- an antimicrobial material comprises metallic copper, zinc, or silver or a salt of copper, zinc, or silver.
- an antimicrobial material comprising a metal can also provide thermal conductivity modulation.
- an antimicrobial material comprises an organic composition, including natural and synthetic organic compositions.
- an antimicrobial material comprises a P-lactam such as a penicillin or cephalosporin.
- an antimicrobial material comprises a protein synthesis inhibitor such as neomycin.
- an antimicrobial material comprises an organic acid, such as lactic acid, acetic acid, or citric acid.
- an antimicrobial material comprises a quarternary ammonium species.
- a quarternary ammonium species in some embodiments, comprises a long alkyl chain, such as an alkyl chain having a C8 to C28 backbone.
- an antimicrobial material comprises one or more of benzalkonium chloride, benzethonium chloride, methylbenzethonium chloride, cetalkonium chloride, cetylpyridinium chloride, cetrimonium, cetrimide, dofanium chloride, tetraethylammonium bromide, didecyldimethylammonium chloride, and domiphen bromide.
- a pH modulator and/or an ionic liquid may also be an antimicrobial material.
- the first component and/or the second component further comprises an organic phase change material (PCM).
- an organic PCM comprises a fatty acid.
- a fatty acid can have a C4 to C28 aliphatic hydrocarbon tail.
- a “Cn-Cm” aliphatic hydrocarbon, alkyl, or similar alkylene moiety e.g., a “C4-C28 aliphatic hydrocarbon or alkylene moiety”
- n-Cm aliphatic hydrocarbon, alkyl, or similar alkylene moiety
- a bivalent saturated aliphatic radical having from “n” to “m” carbon atoms (e.g., 4 to 28 carbon atoms, and no more than 28 carbon atoms).
- Non-limiting examples of fatty acids suitable for use in some embodiments described herein include caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, arachidic acid, behenic acid, lignoceric acid, and cerotic acid.
- an oxidized fatty component described herein comprises a plurality of differing fatty acids.
- an organic PCM comprises an analogue of a fatty acid.
- an analogue of a fatty acid comprises a fatty sulfonate or phosphonate. Any fatty sulfonate or phosphonate not inconsistent with the objectives of the present invention may be used.
- an organic phase change material comprises a C4 to C28 alkyl sulfonate or phosphonate.
- an organic phase change material comprises a C4 to C28 alkenyl sulfonate or phosphonate.
- an organic PCM comprises a polyethylene glycol. Any polyethylene glycol not inconsistent with the objectives of the present invention may be used.
- an organic PCM described herein comprises an alkyl ester of a fatty acid. Any alkyl ester not inconsistent with the objectives of the present invention may be used.
- an alkyl ester comprises a methyl, ethyl, propyl, or butyl ester of a fatty acid described herein.
- an alkyl ester comprises a C2 to C6 ester alkyl backbone or a C6 to C12 ester alkyl backbone.
- an alkyl ester comprises a C12 to C28 ester alkyl backbone.
- an organic PCM described herein comprises a plurality of differing alkyl esters of fatty acids.
- alkyl esters of fatty acids suitable for use in some embodiments described herein include methyl laurate, methyl myristate, methyl palmitate, methyl stearate, methyl palmitoleate, methyl oleate, methyl linoleate, methyl docosahexanoate, and methyl ecosapentanoate.
- the corresponding ethyl, propyl, or butyl esters may also be used.
- an organic phase change material described herein comprises a fatty alcohol.
- a fatty alcohol in some embodiments, can have a C4 to C28 aliphatic hydrocarbon tail.
- the hydrocarbon tail is saturated.
- the hydrocarbon tail is unsaturated.
- the hydrocarbon tail can be branched or linear.
- Non-limiting examples of fatty alcohols suitable for use in some embodiments described herein include capryl alcohol, pelargonic alcohol, capric alcohol, undecyl alcohol, lauryl alcohol, tridecyl alcohol, myristyl alcohol, pentadecyl alcohol, cetyl alcohol, heptadecyl alcohol, stearyl alcohol, nonadecyl alcohol, arachidyl alcohol, heneicosyl alcohol, behenyl alcohol, lignoceryl alcohol, ceryl alcohol, and montanyl alcohol.
- an oxidized fatty component described herein comprises a plurality of differing fatty alcohols.
- an organic PCM component in some embodiments, comprises a mixture or combination of one or more fatty acids, fatty alcohols, and/or alkyl esters of fatty acids described herein. Any combination not inconsistent with the objectives of the present invention may be used.
- an organic PCM component comprises one or more fatty acids and one or more fatty alcohols.
- the first component and/or the second component further comprises an inorganic PCM component.
- an inorganic component comprises a salt hydrate.
- Suitable salt hydrates include, without limitation, CaCh • 6H2O and/or other CaCh hydrates, Ca(NO 3 ) 2 • 3H 2 O, NaSCh • 10H 2 O, Na(NO 3 ) 2 • 6H 2 O, Zn(NO 3 ) 2 • 2H 2 O, FeCh • 2 H 2 O, Co(NO 3 ) 2 • 6H2O, Ni(NO 3 ) 2 ’6H 2 O, MnCh • 4H 2 O, CH 3 COONa • 3H 2 O, LiC 2 H 3 O 2 • 2H 2 O, MgCl 2 • 4H 2 O, NaOH • H 2 O, Cd(NO 3 ) 2 • 4H 2 O, Cd(NO 3 )2 • 1H 2 O, Fe(NO 3 ) 2 • 6H 2 O, NaAl
- the first component and/or the second component further comprises a pH modulator.
- a pH modulator can be acidic or basic, in the sense of lowering/decreasing or raising/increasing the pH of the component.
- the pH modulator lowers the pH of the shape stable phase change material composition, compared to what the pH would be if the pH modulator were absent (or of a precursor mixture of the composition).
- the pH modulator raises the pH of the composition, compared to what the pH would be if the pH modulator were absent. Any pH modulator not inconsistent with the objectives of the present disclosure may be used.
- the pH modulator comprises an organic acid or an organic base.
- the pH modulator comprises citric acid, a citrate salt (such as mono-, di-, or tri-sodium citrate), lactic acid, a salt of lactic acid, or acetic acid.
- the pH modulator comprises an inorganic acid or base.
- an inorganic acid comprises HC1, H2SO 4 , or HN0 3
- an inorganic base comprises NaOH or KOH.
- a first component or second component described herein comprises or contains more than one pH modulator.
- the first component and/or the second component described herein comprises at least two pH modulators.
- a first pH modulator in some embodiments, lowers the pH of the shape stable phase change material composition.
- the first pH modulator raises the pH of the composition.
- a second pH modulator may be selected to further modify the pH of the composition in combination with the first pH modulator.
- a second pH modulator may further lower the pH of the shape stable phase change material composition where the first pH modulator lowers the pH of the composition.
- a second pH modulator may raise the pH of the shape stable phase change material composition while the first pH modulator lowers the pH of the composition.
- the second pH modulator may also raise the pH of the shape stable phase change material composition or may lower the pH of the composition.
- a first component and/or a second component comprises a catalyzing agent.
- the catalyzing agent can be a pH modulator or kinetic control agent described hereinabove.
- the first component comprises a first catalyzing agent
- the second component comprises a second catalyzing agent.
- the first catalyzing agent increases the rate of crosslinking of components to form the shape stable PCM, upon contact of the first component with the second component, but not before.
- the first catalyzing agent can initiate or increase the rate of reaction or crosslinking of a material that is present in the second component but not in the first component.
- the second catalyzing agent (which is present in the second component but not the first component) increases the rate of crosslinking of components to form the shape stable PCM, upon contact of the first component with the second component, but not before.
- the second catalyzing agent can initiate or increase the rate of reaction or crosslinking of a material that is present in the first component but not in the second component.
- the first component described herein comprises a first catalyzing agent and a first crosslinker
- the second component comprises a second catalyzing agent and a second crosslinker.
- the first catalyzing agent (present in the first component) initiates or increases the rate of crosslinking carried out by the second crosslinker (present in the second component), but does not initiate or increase the rate of crosslinking carried out by the first crosslinker (present in the first component).
- the second catalyzing agent (present in the second component) initiates or increases the rate of crosslinking carried out by the first crosslinker (present in the first component), but does not initiate or increase the rate of crosslinking carried out by the second crosslinker (present in the second component).
- a composition or a first component and/or second component described herein can comprise water in addition to other species or materials.
- water is present in a composition or a first component and/or second component described herein as the “balance” making up 100 wt. % in combination with other species or materials present.
- a composition or a first component and/or second component described herein comprises up to 95 wt. %, up to 90 wt. %, up to 85 wt. %, up to 80 wt. %, up to 75 wt. %, or up to 70 wt.
- a composition or a first component and/or second component described herein comprises 10-95 wt. %, 10-90 wt. %, 10-85 wt. %, 10-80 wt. %, 10-75 wt. %, 10-70 wt. %, 10-60 wt. %, 10-50 wt. %, 10-40 wt. %, 10-30 wt. %, 20-95 wt. %, 20-90 wt. %, 20-85 wt. %, 20-80 wt. %, 20-75 wt.
- % 40-60 wt. %, 50-95 wt. %, 50-90 wt. %, 50-85 wt. %, 50-80 wt. %, 50-75 wt. %, 50-70 wt. %, 60-95 wt. %, 60-90 wt. %, 60-85 wt. %, 60-80 wt. %, 60-75 wt. %, or 60-70 wt. % water, based on the total weight of the composition, first component, and/or second component, respectively.
- Table 2 provides non-limiting examples of a first component described herein.
- First Component (“First Comp.” or “FC” in Table 2)
- the weight percents (based on a total weight of 100 wt. % of the first component) for various materials or subcomponents are provided. That is, the values in Table 2 are the weight percents of the identified materials and subcomponents.
- Linker refers to a crosslinker
- pHM refers to pH modulator
- KCA kinetic control agent
- Filler refers to a filler
- Ion. Liq.” refers to ionic liquid
- FR refers to fire retardant
- PM refers to polymeric material
- AM refers to antimicrobial material
- APCM refers to additional PCM, wherein the PCM comprises an organic PCM or an inorganic PCM
- Cat.” refers to catalyzing agent.
- Hyphens (“— ”) indicate the absence of a material.
- Table 3 provides the identities of the various subcomponents of the First Components from Table 2.
- polysacch refers to a polysaccharide
- Zr refers to zirconium compound or complex
- BA boric acid
- BO borate
- zeol refers to zeolite
- FPF fire retardant foam
- AMOC antimicrobial organic composition
- pyr refers to pyridinium based ionic liquid
- chol refers to choline-containing ionic liquid.
- ORC refers to an organocatalyst. In Tables 2 and 3, the balance to make 100 wt. % is water. [0075] Similarly, Table 4 provides non-limiting examples of a second component described herein.
- Table 4 for each example Second Component (“Sec. Comp.” or “SC” in Table 4), the weight percents (based on a total weight of 100 wt. % of the second component) for various materials or subcomponents are provided, using the same abbreviations as in Tables 2 and 3. That is, the values in Table 4 are the weight percents of the identified materials and subcomponents.
- Table 5 provides the identities of the various subcomponents of the Second Components from Table 4, using the same abbreviations as in Table 3. In Tables 4 and 5, the balance to make 100 wt. % is water.
- Table 6 provides combinations (“Comb.” in Table 6) of specific First Components with specific Second Components from Tables 2-5.
- a first fluid stream containing the first component and a second fluid stream containing the second component intersect in a homogenization chamber to provide the crosslinking matrix.
- the complete or substantially complete homogenization of the first and second components occurs within the homogenization chamber and before leaving the homogenization chamber.
- the resulting PCM composition is dispensed into a reaction vessel.
- Embodiment 1 A method of forming a shape stable phase change material, the method comprising: combining a first component and a second component to provide a crosslinking matrix; and dispensing the crosslinking matrix into a reaction vessel under conditions whereby the crosslinking matrix crosslinks to form the shape stable phase change material, wherein the conditions whereby the crosslinking matrix crosslinks to form the shape stable phase change material comprise a period of time between 1 second and 100 hours; wherein the first component is flowable at temperatures above 0°C at 1 atm; wherein the second component is flowable at temperatures above 0°C at 1 atm; and wherein the shape stable phase change material is shape stable at temperatures above 0°C at 1 atm.
- Embodiment 2 The method of Embodiment 1, wherein the crosslinking matrix comprises a polyol.
- Embodiment 3 The method of Embodiment 1 or Embodiment 2, wherein the crosslinking matrix comprises a saccharide and the saccharide comprises a monosaccharide, disaccharide, oligosaccharide, or polysaccharide.
- Embodiment 4 The method of any of Embodiments 1-3, wherein the crosslinking matrix comprises a sugar alcohol and the sugar alcohol comprises glycol, glycerol, erythritol, threitol, arabitol, xylitol, ribitol, mannitol, sorbitol, dulcitol, iditol, isomalt, maltitol, or lactitol.
- combining the first component and the second component to provide the crosslinking matrix comprises combining the first component and the second component in a ratio of the first component to the second component of between about 70:30 and about 90: 10 by volume.
- Embodiment 6 The method of any of Embodiments 1-4, wherein combining the first component and the second component to provide the crosslinking matrix comprises combining the first component and the second component in a ratio of the first component to the second component of between about 70:30 and about 85: 15 by volume.
- Embodiment 7 The method of any of Embodiments 1-4, wherein combining the first component and the second component to provide the crosslinking matrix comprises combining the first component and the second component in a ratio of the first component to the second component of between about 70:30 and about 80:20 by volume.
- Embodiment 8 The method of any of Embodiments 1-4, wherein combining the first component and the second component to provide the crosslinking matrix comprises combining the first component and the second component in a ratio of the first component to the second component of about 75:25 by volume.
- Embodiment 9 The method of any of Embodiments 1-8, wherein combining the first component and the second component to provide the crosslinking matrix comprises adding the first component in a first fluid stream and adding the second component in a second fluid stream.
- Embodiment 10 The method of Embodiment 9, wherein combining the first component and the second component to provide the crosslinking matrix comprises directing the first fluid stream and the second fluid stream to intersect in a homogenization chamber.
- Embodiment 11 The method of Embodiment 10, wherein the homogenization chamber is suspended above the reaction vessel.
- Embodiment 12 The method of Embodiment 11, wherein dispensing the crosslinking matrix into the reaction vessel comprises gravity feeding the crosslinking matrix from the homogenization chamber to the reaction vessel.
- Embodiment 13 The method of Embodiment 10, wherein the first fluid stream is flowed towards the homogenization chamber through a first nozzle and the second fluid stream is flowed towards the homogenization chamber through a second nozzle.
- Embodiment 14 The method of Embodiment 13, wherein the first nozzle has a first diameter, the second nozzle has a second diameter, and a ratio of the first diameter to the second diameter corresponds to a volumetric ratio of the first component to the second component, within 10%.
- Embodiment 15 The method of Embodiment 14, wherein the ratio of the first diameter to the second diameter is between about 70:30 and about 90: 10 or between about 70:30 and 85: 15.
- Embodiment 16 The method of Embodiment 14, wherein the ratio of the first diameter to the second diameter is between about 70:30 and 80:20.
- Embodiment 17 The method of Embodiment 14, wherein the ratio of the first diameter to the second diameter is about 75:25.
- Embodiment 18 The method of any of Embodiments 1-17, wherein the first component comprises at least a first linker component and the second component comprises at least a second linker component which can crosslink to form the shape stable phase change material.
- Embodiment 19 The method of Embodiment 18, wherein the first linker component and the second linker component crosslink to form the shape stable phase change material over a period of at least 1 hour at 0°C and 1 atm in the absence of the second component, and over a period of less than 1 hour, less than 30 minutes, less than 15 minutes, or less than 5 minutes at 0°C and 1 atm in the presence of the second component.
- Embodiment 20 The method of Embodiment 18, wherein the first linker component and the second linker component crosslink to form the shape stable phase change material over a period of at least 3 hours at 0°C and 1 atm in the absence of the second component, and over a period of less than 3 hours, less than 2 hours, less than 1 hour, less than 30 minutes, less than 15 minutes, or less than 5 minutes at 0°C and 1 atm in the presence of the second component.
- Embodiment 21 The method of Embodiment 18, wherein the first component or the second component comprises at least one catalyzing agent operable to increase a rate of crosslinking between the first linker component and the second linker component.
- Embodiment 22 The method of any of Embodiments 1-21, wherein the first component or the second component comprises at least one pH modulator.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Thermal Sciences (AREA)
- Physics & Mathematics (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Combustion & Propulsion (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
Abstract
In one aspect, methods of forming a shape stable phase change material are described herein. In some embodiments, such a method comprises combining a first component and a second component to provide a crosslinking matrix, and dispensing the crosslinking matrix into a reaction vessel under conditions whereby the crosslinking matrix crosslinks to form the shape stable phase change material. In some instances, the conditions whereby the crosslinking matrix crosslinks to form the shape stable phase change material comprise a period of time between 1 second and 100 hours. In other such embodiments, the first component is flowable at temperatures above 0°C at 1 atm, and the second component is flowable at temperatures above 0°C at 1 atm. In some instances, the shape stable phase change material is shape stable at temperatures above 0°C at 1 atm.
Description
METHODS OF MAKING SHAPE STABLE PHASE CHANGE MATERIAL
COMPOSITIONS
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application claims priority pursuant to 35 U.S.C. § 119 to U.S. Provisional Patent Application No. 63/423,832, filed November 9, 2022, which is hereby incorporated by reference in its entirety.
FIELD
[0002] The present disclosure relates to methods of making thermal energy storage or phase change material (PCM) compositions.
BACKGROUND
[0003] In recent years, latent heat storage has become increasingly important in a wide array of technologies. Latent heat includes thermal energy released or absorbed during a change of state of a material without a change or substantial change in the temperature of the material. The change of state can include a phase change such as a solid-liquid, solid-gas, liquid-gas, or solidsolid phase change, including a crystalline solid to amorphous solid phase change or other solid- to-solid phase change. Because of their latent heat storage properties, phase change materials (PCMs) have found application in a wide array of thermal energy and temperature control technologies. However, the use of PCMs has been limited in some instances by disadvantages associated with the thermal energy storage capacity and/or form of certain PCMs. For example, some materials suffer from large volume changes and/or flow in a liquid state. Improved compositions are therefore desired for thermal energy storage and other applications.
[0004] Improved methods of making PCMs or PCM compositions are also desired. Some existing methods can be slow or can require frequent maintenance or repair of manufacturing equipment, including due to the nature of the PCM compositions or their components. Such manufacturing limitations can significantly hinder the widespread use of such PCM compositions.
SUMMARY
[0005] In one aspect, compositions and methods of making compositions for thermal energy storage are contemplated herein which, in some embodiments, may offer one or more advantages over prior compositions and methods. In some embodiments, for example, a composition described herein exhibits a high latent heat during a solid-to-solid or shape-stable transition, thereby providing a composition that is useful in various applications in which shape stability and/or elimination of flow in the “melted” phase is relevant. Such applications can include thermal energy storage and temperature control applications.
[0006] For example, in some embodiments, a composition described herein comprises 0.5-10 wt. % polysaccharide or polysaccharide component, and 88-99.5 wt. % water, wherein the weight percentages are based on the total weight of the composition. Further, in some instances, the composition is shape stable at 20°C and 1 atm for at least 24 hours or for a longer time period, as described further below. In other embodiments, the composition has a dynamic viscosity of greater than or equal to 300,000 cP at 20°C and 1 atm. Moreover, in some implementations, the polysaccharide of a composition described herein comprises a cellulose, cellulose ether, starch, seaweed gum or seaweed hydrocolloid (such as an alginate or alginic acid, an agar, or a carrageenan), chitosan, gum Arabic, locust bean gum, guar gum, xanthan gum, or a combination of two or more of the foregoing. Additionally, in some embodiments, any of the foregoing polysaccharides can be functionalized or chemically modified, such as by alkoxylation, alkylation, or other functionalization. A composition described herein can also comprise or include one or more additional species or components, in addition to water and a polysaccharide. For example, in some cases, a composition described herein further comprises a pH modulator, such an inorganic or organic acid or base. In some instances, the pH modulator lowers the pH of the composition, while in other cases the pH modulator raises the pH of the composition. It is also possible for more than pH modulator to be used. Further, in some implementations, a composition described herein further comprises an ionic liquid, a kinetic control agent, a filler (e.g., a solid filler), a fire retardant, a polymeric material (other than or in addition to the polysaccharide), and/or an antimicrobial material. Moreover, in some embodiments, a composition described herein further comprises at least one organic PCM. [0007] Methods of making such PCM compositions are also described in the present disclosure. Such methods, in some cases, can be used to make or prepare a composition
described or referred to above. In some embodiments, a method of forming a shape stable PCM described herein comprises combining a first component and a second component to provide a crosslinking matrix. The method further comprises dispensing the crosslinking matrix into a reaction vessel under conditions whereby the crosslinking matrix crosslinks to form the shape stable phase change material. Moreover, in some cases, the conditions whereby the crosslinking matrix crosslinks to form the shape stable phase change material comprise a period of time between 1 second and 100 hours. In some embodiments, the crosslinking matrix crosslinks to form the shape stable phase change material in a period of time between 1 second and 1 hour, between 1 second and 30 minutes, between 1 second and 10 minutes, or between 1 second and 5 minutes. Further, in some implementations, the first component and/or the second component is, individually, flowable at temperatures above 0°C at 1 atm. In addition, in some embodiments, the shape stable PCM formed by the method is shape stable at temperatures above 0°C at 1 atm. [0008] In some cases, combining the first component and the second component to provide the crosslinking matrix comprises combining the first component and the second component in a particular ratio, such as a ratio of the first component to the second component of between about 70:30 and about 90: 10 by volume. In some instances, combining the first component and the second component to provide the crosslinking matrix comprises combining the first component and the second component in a ratio of the first component to the second component of between about 70:30 and about 85: 15 by volume or between about 70:30 and about 80:20 by volume. In other embodiments, combining the first component and the second component to provide the crosslinking matrix comprises combining the first component and the second component in a ratio of the first component to the second component of about 75:25 by volume.
[0009] Moreover, in some instances, combining the first component and the second component to provide the crosslinking matrix comprises adding or disposing the first component in a first fluid stream and adding or disposing the second component in a second fluid stream, and the first fluid stream is combined with the second fluid stream. Further, in some such implementations, combining the first component and the second component to provide the crosslinking matrix comprises directing the first fluid stream and the second fluid stream to intersect in a homogenization chamber. The homogenization chamber may be suspended above the reaction vessel, such that dispensing the crosslinking matrix into the reaction vessel
comprises gravity feeding the crosslinking matrix from the homogenization chamber to the reaction vessel.
[0010] Additionally, in some instances, the first fluid stream is flowed towards the homogenization chamber through a first nozzle, and the second fluid stream is flowed towards the homogenization chamber through a second nozzle. In some such embodiments, the first nozzle has a first diameter, and the second nozzle has a second diameter. Additionally, in some implementations, a ratio of the first diameter to the second diameter corresponds to a volumetric ratio of the first component to the second component, within 10%. In some embodiments, the ratio of the first diameter to the second diameter is between about 70:30 and about 90: 10, between about 70:30 and about 80:20, or between about 70:30 and 85: 15. In some other instances, the ratio of the first diameter to the second diameter is about 75:25.
[0011] Moreover, in some embodiments, the first component comprises or includes at least a first linker and/or the second component comprises or includes at least a second linker component. In some embodiments, the first linker component and/or the second linker component, when combined with other species present in the first component and/or second component, can crosslink to make the resulting PCM or composition shape stable or substantially shape stable under desired conditions. For example, in some cases, the first linker component and the second linker component are both present, and the two linker components can crosslink to form the shape stable PCM or to provide shape stability to the PCM. Moreover, in some instances, the first linker component and the second linker component crosslink to form the shape stable phase change material over a period of at least 1 hour at 0°C and 1 atm in the absence of the second component, and over a period of less than 1 hour, less than 30 minutes, less than 15 minutes, or less than 5 minutes at 0°C and 1 atm in the presence of the second component. That is, in some cases, the rate of crosslinking of the first linker component with the second linker component differs, depending on whether the second component is present or absent. In other embodiments, the first linker component and the second linker component crosslink to form the shape stable phase change material over a period of at least 3 hours at 0°C and 1 atm in the absence of the second component, and over a period of less than 3 hours, less than 2 hours, less than 1 hour, less than 30 minutes, less than 15 minutes, or less than 5 minutes at 0°C and 1 atm in the presence of the second component.
[0012] Additionally, in some such embodiments, the first component and/or the second component comprises at least one catalyzing agent operable to increase a rate of crosslinking between the first linker component and the second linker component (or to increase the rate of crosslinking of the first linker component with itself, or of the second linker component with itself). In other such embodiments, the first component and/or the second component comprises at least one pH modulator. Moreover, in some instances, the first component comprises a first catalyzing agent and/or a first pH modulator, and the second component comprise a second catalyzing agent and/or a second pH modulator.
[0013] Similarly, in some embodiments, the first component comprises a first ionic liquid, a first kinetic control agent, a first filler (e.g., a first solid filler), a first fire retardant, a first polymeric material (other than or in addition to the polysaccharide), a first antimicrobial material, a first organic PCM, or a combination of two or more of the foregoing; and the second component comprises a second ionic liquid, a second kinetic control agent, a second filler (e.g., a second solid filler), a second fire retardant, a second polymeric material (other than or in addition to the polysaccharide), a second antimicrobial material, a second organic PCM, or a combination of two or more of the foregoing.
[0014] These and other embodiments are described in greater detail in the description which follows.
BRIEF DESCRIPTION OF THE DRAWINGS
[0015] Figure l is a schematic representation of a first component flowing toward a second component to be combined in a homogenization chamber to provide a crosslinking matrix to feed downward to a reaction vessel, according to some embodiments described herein.
[0016] Figure 2 is a schematic representation of a first component flowing toward a second component to be combined in a homogenization chamber wherein the diameter of the first nozzle is larger than that of the diameter of the second nozzle, according to some embodiments described herein.
DETAILED DESCRIPTION
[0017] Implementations and embodiments described herein can be understood more readily by reference to the following detailed description and examples. Elements, apparatus, and
methods described herein, however, are not limited to the specific implementations presented in the detailed description and examples. It should be recognized that these implementations are merely illustrative of the principles of the present disclosure. Numerous modifications and adaptations will be readily apparent to those of skill in the art without departing from the spirit and scope of the disclosure.
[0018] In addition, all ranges disclosed herein are to be understood to encompass any and all subranges subsumed therein. For example, a stated range of “1.0 to 10.0” should be considered to include any and all subranges beginning with a minimum of 1.0 or more and ending with a maximum value of 10.0 or less, e.g., 1.0 to 5.3, or 4.7 to 10.0, or 3.6 to 7.9. Similarly, as will be clearly understood, a stated range of “1 to 10” should be considered to include any and all subranges beginning with a minimum of 1 or more and ending with a maximum value of 10 or less, e.g., 1 to 6, or 7 to 10, or 3.6 to 7.9.
[0019] All ranges disclosed herein are also to be considered to include the end points of the range, unless expressly stated otherwise. For example, a range of “between 5 and 10,” “from 5 to 10,” or “5-10” should generally be considered to include the end points of 5 and 10.
[0020] Further, when the phrase “up to” is used in connection with an amount or quantity, it is to be understood that the amount is at least a detectable amount or quantity. For example, a material present in an amount “up to” a specified amount can be present from a detectable amount and up to and including the specified amount.
[0021] Additionally, in any disclosed embodiment, the terms “substantially,” “approximately,” and “about” may be substituted with “within [a percentage] of’ what is specified, where the percentage could be 0.1, 1, 5, or 10 percent, unless the use of such a term in a given instance indicates otherwise.
[0022] It is also to be understood that the article “a” or “an” refers to “at least one,” unless the context of a particular use requires otherwise.
[0023] In one aspect, methods of forming a shape stable phase change material are described herein. In some embodiments, such a method comprises combining a first component and a second component to provide a crosslinking matrix and dispensing the crosslinking matrix into a reaction vessel under conditions whereby the crosslinking matrix crosslinks to form the shape stable phase change material. Additionally, as described further herein, in some cases, these conditions comprise a specified time period, a specified temperature, and/or a specified
temperature. For example, in some instances, the conditions comprise a period of time between 1 second and 100 hours, between 1 second and 1 hour, between 1 second and 30 minutes, between 1 second and 10 minutes, or between 1 second and 5 minutes. The time period can also be a time period within a subrange of the foregoing ranges. In some cases, the conditions comprise a pressure between 0.9 and 1.1 atm. Additionally, in some instances, the conditions comprise a temperature between 20°C and 80°C, between 20°C and 70°C, between 20°C and 60°C, between 20°C and 50°C, between 20°C and 40°C, between 20°C and 35°C, between 20°C and 30°C, between 25°C and 70°C, between 25°C and 60°C, between 25°C and 50°C, between 25°C and 40°C, or between 25°C and 35°C.
[0024] Further, in some instances, the first component and/or the second component is flowable at temperatures above 0°C at 1 atm. In other embodiments, the first component and/or the second component is predominantly aqueous (e.g., the formed shape stable PCM contains at least 88% water). In some implementations, the first component and/or the second component is stable at temperatures above 0°C at 1 atm. For example, the first component and/or the second component may form no visually observable paste or gel over a specified period of time. Further, in some cases, a stable component (e.g., a “stable” first component and/or a “stable” second component) exhibits less than a 10% change (e.g., increase) or less than a 5% change (e.g., increase) in dynamic viscosity over a given time period at a given temperature (e.g., over the course of 12 hours or 1 day at a temperature of 15-3O°C). In some embodiments, the first component and/or the second component is stable (e.g., no change or less than 10% or 5% change in dynamic viscosity and/or no visually observable paste or gel formation) at 1 atm at a temperature above 0°C (e.g., at a temperature of 15-30°C) for 1 week, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 7 months, 8 months, 9 months, 10 months, 11 months, 1 year, 15 months, 18 months, 21 months, or 2 years. In some instances, both the first component and the second component are stable at temperatures above 0°C at 1 atm for 1 week, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 7 months, 8 months, 9 months, 10 months, 11 months, 1 year, 15 months, 18 months, 21 months, or 2 years.
[0025] Certain steps and features of methods according to the present disclosure will now be described in more detail. Methods described herein comprise combining a first component and a second component to provide a crosslinking matrix. Any first component and/or second component may be used consistent with the present disclosure, as described further hereinbelow.
In some embodiments, the first component comprises at least a first linker component or a plurality of linker components. In some instances, a first component comprises or includes a first linker component and comprises or includes a second linker component. In some such embodiments, the first and second linker components, when combined, crosslink to make the resulting phase change material or composition shape stable or substantially shape stable under desired conditions.
[0026] Moreover, in some embodiments, a composition described herein exhibits a high latent heat during a solid-to-solid or shape-stable transition, thereby providing a composition that is useful in various applications in which shape stability and/or elimination of flow in the “melted” phase are relevant. Such applications can include thermal energy storage and temperature control applications.
[0027] Moreover, in some cases, such a composition is self-supporting or shape stable, including at ambient or other moderate temperature and pressure. For example, in some embodiments, a composition is shape stable (including without support by side walls or a container or the like) at temperatures above 0°C at 1 atm, such as at one or more temperatures selected from Table 1 below. In other instances, the composition is shape stable at 20°C and 1 atm. Additionally, the relative humidity may be 50%.
[0028] Such a shape stable composition, in some implementations, does not deform or flow substantially under these conditions for more than 1 hour, more than 2 hours, more than 5 hours,
or more than 12 hours. In some implementations, the composition is solid or is shape-stable and does not flow or deform for 1-24 hours, 1-12 hours, 2-18 hours, or 2-6 hours under the conditions described above.
[0029] Moreover, in some instances, a composition made by a method described herein may have some fluidity, such as may be exhibited by a paste or gel. For example, in some cases, a composition described herein has a dynamic viscosity of greater than or equal to 300,000 cP at 20°C and 1 atm. A composition made by a method described herein may also comprise a network, such as a crosslinked polysaccharide network or other network. Moreover, in some instances, a composition made by a method described herein comprises a polysaccharide network (or other network) including many hydrogen bonds with water. Additionally, not intending to be bound by theory, the water may form a continuous phase within a scaffolding formed by the polysaccharide (or other material).
[0030] Compositions described herein can have any pH not inconsistent with the objectives of the present disclosure. For example, a composition described herein can have a pH of between about 2 and about 12, such as between about 2 and about 7, between about 7 and about 12, between about 5 and about 7, between about between about 3 and about 7, between about 4 and about 7, between about 5 and about 7, or between about 6 and about 7. Further, a pH of a composition described herein can be between about 7 and about 12, between about 8 and about 12, between about 8 and about 12, between about 9 and about 12, between about 10 and about 12, or between about 11 and about 12. Moreover, a composition described herein may have a pH of between about 7 and about 11, between about 7 and about 10, between about 7 and about 9, or between about 7 and about 8. Additionally, a composition described herein may have a pH between about 5 and about 9, such as between about 5 and about 8, between about 6 and about 9, or between about 6 and about 8, between about 6 and about 7, or between about 7 and about 8. Not intending to be bound by theory, the use of one or more pH modulators can permit a composition described herein to be prepared and/or used across a variety of pH ranges.
[0031] Further, the first component and second component may be combined in any ratio consistent with the objectives of the present disclosure. For example, in some embodiments, a ratio (by volume) of the first component to the second component in the crosslinking matrix is between about 50:50 and about 90: 10, such as between about 60:40 and about 90: 10, between about 70:30 and 90: 10, or between about 70:30 and 80:20. The ratio in the crosslinking matrix
may also be about 75:25 by volume. In some cases, combining the first component and the second component to provide the crosslinking matrix comprises combining the first component and the second component in a ratio of the first component to the second component of between about 70:30 and about 90:10 by volume, between about 70:30 and about 85: 15 by volume, between about 70:30 and about 80:20 by volume, or in a ratio of about 75:25 by volume. [0032] Combining the first component and the second component to provide the first crosslinking matrix can be carried out in any manner not inconsistent with the objectives of the present disclosure. For example, in some embodiments, combining the first component and the second component to provide the crosslinking matrix comprises adding or disposing the first component in a first fluid stream and adding or disposing the second component in a second fluid stream. Further, in some cases, as shown in the non-limiting example of Figure 1, a method (100) comprises directing the first fluid stream (101) and the second fluid stream (102) to intersect in a homogenization chamber (103) to provide the crosslinking matrix (104), and dispensing the crosslinking matrix into the reaction vessel (105) comprises gravity feeding or otherwise free-flowing the crosslinking matrix from the homogenization chamber to the reaction vessel (105), as indicated by the arrow in Figure 1. In some such embodiments, the turbulence caused by flowing the streams towards one another causes the mixing or homogenization without further agitation. Additionally, in some implementations, complete or substantially complete homogenization of the first and second components occurs in-line (e.g., within the homogenization chamber and before leaving the homogenization chamber). Such homogenization may also occur within a short period of time (e.g., in 10 seconds or less, 5 seconds or less, 3 seconds or less, or less than 1 second). Homogenizing the first and second components in a manner described herein, in some cases, can reduce or prevent clogging of the manufacturing equipment, which may otherwise occur due to crosslinking of the components in situ.
[0033] Combining the first component and the second component to provide the first crosslinking matrix can be carried out at any temperature not inconsistent with the objectives of the present invention. In some instances, combining the first component and the second component is carried out at a temperature of 0°C-50°C, 0°C-40°C, 0°C-30°C, 0°C-20°C, 0°C- 10°C, 10°C-50°C, 10°C-40°C, 10°C-30°C, 10°C-20°C, 20°C-50°C, 20°C-40°C, 20°C-30°C, 30°C-50°C, 30°C-40°C, or 40°C-50°C at 1 atm.
[0034] Moreover, in some embodiments, directing and/or flowing the first component and the second component toward one another may be controlled volumetrically. Not intending to be bound by theory, it is believed that such volumetric control can maintain or substantially maintain a ratio of the first component to the second component upon entering the homogenization chamber. In some embodiments, this volumetric control may be implemented by flowing the first component through a first nozzle having a first nozzle diameter and flowing the second component through a second nozzle having a second nozzle diameter (e.g., at the same applied force). The first and second nozzle diameters may be sized, as by diameter, to have a specific ratio relative to one another. For example, in some embodiments, a ratio of the first diameter to the second diameter is between about 50:50 and about 90:10, such as between about 60:40 and about 90: 10, between about 70:30 and about 90: 10, or between about 70:30 and about 80:20. Further, in some embodiments, the ratio of the first diameter to the second diameter is about 75:25. In some cases, the ratio of the first diameter to the second diameter corresponds to a volumetric ratio of the first component to the second component, within 10%.
[0035] A non-limiting example embodiment (200) of such a method is shown in Figure 2. With reference to Figure 2, a first component (201) flows through a first nozzle (202) having a first nozzle diameter toward the homogenization chamber (203). A second component (204) flows through a second nozzle (205) having a second nozzle diameter toward the homogenization chamber (203). The diameter of the first nozzle is larger than that of the diameter of the second nozzle. The first component and second component combine in the homogenization chamber to provide the crosslinking matrix (206). Dispensing the crosslinking matrix into the reaction vessel (207) comprises gravity feeding or otherwise free-flowing the crosslinking matrix from the homogenization chamber to the reaction vessel (207).
[0036] Any homogenization chamber consistent with the present objectives may be used. For example, in some embodiments, the homogenization chamber may be a T-connector, permitting fluid flow from opposing sides of the connector with a third opening for releasing the crosslinking matrix from the homogenization chamber. In such cases, a first fluid stream comprising the first component can enter a first side of the T-connector and a second fluid stream comprising the second component can enter a second, opposing side of the T-connector. Further, in some embodiments, the homogenization chamber is suspended above a reaction vessel. In such embodiments, dispensing the crosslinking matrix into the reaction vessel comprises gravity
feeding or otherwise free-flowing the crosslinking matrix from the homogenization chamber to the reaction vessel.
[0037] A homogenization chamber may also be at any temperature not inconsistent with the objectives of the present invention. In some embodiments, a homogenization chamber may be between 0°C-50°C, between 0°C-40°C, between 0°C-30°C, between 0°C-20°C, between 0°C- 10°C, between 10°C-50°C, between 10°C-40°C, between 10°C-30°C, between 10°C-20°C, between 20°C-50°C, between 20°C-40°C, between 20°C-30°C, between 30°C-50°C, between 30°C-40°C, or between 40°C-50°C at 1 atm.
[0038] Turning again to the first and second components, in some implementations described herein, the first component comprises at least a first linker component and at least a second linker component which can crosslink to form the shape stable phase change material. Such a linker component may also be referred to herein as a “crosslinker component” or a “crosslinker.” In some instances, as described further hereinbelow, such crosslinking can comprise chemical crosslinking, such as may be achieved by the formation of one or more covalent bonds, one or more hydrogen bonds, or one or more other bonds having sufficient bond strength or binding energy to form a crosslinked network, which may be chemically and/or physically stable in an aqueous environment for at least 1 day, at least 3 days, at least 5 days, at least 7 days, at least 10 days, at least 1 month, at least 6 months, or at least 1 year. Such an aqueous environment may have a pH of 4-10 or 6-8, a temperature of -20°C to 50°C, and a pressure of 0.7-1.3 atm or 0.3 to 1.1 atm.
[0039] Moreover, in some instances, a first component comprises at least a first linker component and at least a second linker component, and the first linker component and the second linker component crosslink to form the shape stable phase change material over a relatively short period of time when mixed or combined with the second component of a method described herein, but crosslink over a relatively long period of time (or not at all) in the absence of the second component. For example, in some cases, the first linker component and the second linker component crosslink to form the shape stable phase change material over a period of at least 1 hour at 0°C and 1 atm in the absence of the second component, and over a period of less than 1 hour, less than 30 minutes, less than 15 minutes, or less than 5 minutes at 0°C and 1 atm in the presence of the second component. In some implementations, the first linker component and the second linker component crosslink to form the shape stable phase change material over a period
of at least 3 hours at 0°C and 1 atm in the absence of the second component, and over a period of less than 3 hours, less than 2 hours, less than 1 hour, less than 30 minutes, less than 15 minutes, or less than 5 minutes at 0°C and 1 atm in the presence of the second component. In some instances, the second component comprises at least one catalyzing agent operable to increase a rate of crosslinking between the first linker component and the second linker component. Any catalyzing agent not inconsistent with the objectives of the present disclosure may be used. For instance, in some cases, the catalyzing agent comprises a metal or metal complex or metal compound such as a transition metal or transition metal complex or compound, an enzyme, a non-enzyme organocatalyst, a Lewis acid, a Lewis base, a Bronsted-Lowry acid, or a Bronsted- Lowry base. Moreover, a catalyzing agent described herein may be a true catalyst in the sense the catalyzing agent is not itself consumed as a reagent (e.g., stoichiometrically), or a catalyzing agent may be a reactant that is itself consumed and not necessarily regenerated by the crosslinking reaction or in a reaction step prior to the crosslinking reaction.
[0040] A linker component described herein, in some embodiments, can link or form a network with one or more other components used to make a composition described herein. For example, in some cases, a linker component is chemically bonded to another component of the composition, such as a polysaccharide described herein, which may be described herein as a “linked component.” It is also possible for the “linked component” to itself be a linker component described herein, such that the linker component is crosslinked with itself or with a different linker component. For example, as described elsewhere herein, a first linker component can crosslink with a second linker component to form a network or to form a shape stable phase change material.
[0041] Further, in some embodiments, a linker component chemically bonded to such a linked component provides a non-polymeric material. In some embodiments, a linker component chemically bonded to a linked component provides an oligomeric material. In some embodiments, for example, a linked component is monofunctional. A monofunctional linked component, in some embodiments, can be chemically bonded to a linker component through a single functional group, such as a carboxyl or hydroxyl group. Further, in some embodiments, the linker component is polyfunctional. A polyfunctional crosslinker, in some embodiments, can be chemically bonded to more than one linked component, including more than one monofunctional linked component. For example, in some embodiments, a bifunctional
crosslinker (B) can be chemically bonded to two monofunctional linked components (A) to provide an A-B-A trimer. In other embodiments, a bifunctional crosslinker is chemically bonded to one monofunctional linked component to provide an A-B dimer.
[0042] Further, the crosslinker can be chemically bonded to a linked component through any chemical bond not inconsistent with the objectives of the present invention. In some embodiments, for instance, a linker component is chemically bonded to a linked component through a covalent bond. In other embodiments, the crosslinker is chemically bonded to a linked component through an ionic bond or electrostatic bond. In some embodiments, the crosslinker is chemically bonded to a linked component through a hydrogen bond. In some embodiments, the crosslinker is chemically bonded to a linked component through a urethane bond. In other embodiments, the crosslinker is chemically bonded to a linked component through an amide bond. In some embodiments, the crosslinker is chemically bonded to a linked component through an ester bond.
[0043] In addition, the crosslinker described herein can comprise any chemical species not inconsistent with the objectives of the present disclosure. In some embodiments, for instance, the crosslinker comprises a functional group capable of forming a covalent bond with a functional group of a linked component described herein, such as a carboxyl group or a hydroxyl group. In some embodiments, the crosslinker comprises a polyol. In some embodiments, the crosslinker comprises a saccharide, including a monosaccharide, disaccharide, oligosaccharide, or polysaccharide. In some embodiments, the polysaccharide of a composition described herein comprises a cellulose, a cellulose derivative, cellulose ether, starch, seaweed gum or seaweed hydrocolloid (such as an alginate or alginic acid, an agar, or a carrageenan), chitosan, gum Arabic, locust bean gum, guar gum, xanthan gum, galactomannan polysaccharide, or a combination of two or more of the foregoing. Additionally, in some embodiments, any of the foregoing polysaccharides can be functionalized or chemically modified, such as by alkoxylation, alkylation, or other functionalization, e.g., to provide a cellulose ether. In some cases, the polysaccharide comprises a hydroxyethyl starch, hydroxyethyl polysaccharide, or hydroxy ethylcellulose. In some instances, the polysaccharide comprises a potato starch, corn starch, rice starch, or wheat starch.
[0044] In certain implementations, instead of or in addition to a polysaccharide described herein, a composition (or a first component and/or second component) can comprise or include a
carboxymethyl ether of one or more polysaccharides. For example, in some embodiments, a composition (or a first component and/or second component) described herein comprises or includes a carboxymethyl ether formed or derived from one or more of the following: cellulose, chitin, chitosan, curdlan, dextran, pullulan , schleroglucan, schizophyllan, starch, amylase, amylopectin, seaweed gum or seaweed hydrocolloid (such as an alginate or alginic acid, an agar, or a carrageenan), gum Arabic, locust bean gum , guar gum, or xanthan gum, or a combination of two or more of the foregoing. Carboxymethyl ethers may also be formed from natural, synthetic, or functionalized polysaccharides. Compositions (or a first component and/or second component) described herein may comprise of combinations of carboxymethyl ethers wherein each carboxymethyl ether is derived from a separate member of the foregoing group of polysaccharides.
[0045] Additionally, compositions (or a first component and/or second component) described herein may comprise or include one or more salts of a carboxymethyl ether. For example, in some embodiments, a composition (or a first component and/or second component) described herein comprises sodium starch glycolate.
[0046] A polysaccharide (or related species) described herein can have any molecular weight not inconsistent with the objectives of the present disclosure. For example, in some embodiments, a polysaccharide has a weight average molecular weight between about 2,000 and about 3,000,000, between about 20,000 and 2,500,000, or between about 100,000 and about 2,000,000. Moreover, in some instances, a polysaccharide is present in a composition or crosslinking matrix described herein in an amount of about 0.5-7 wt. % or in an amount of about 1-5 wt. %, based on the total weight of the composition or crosslinking matrix. Additionally, in some cases, a composition or crosslinking matrix comprising a polysaccharide is not a solution or colloid of the polysaccharide. Further, in some such embodiments, water is present in the composition or crosslinking matrix in amount of 90-99 wt.% or in an amount of 95-99.5 wt. %, based on the total weight of the composition or crosslinking matrix.
[0047] Further, in some embodiments, the crosslinker comprises a sugar alcohol, such as glycol, glycerol, erythritol, threitol, arabitol, xylitol, ribitol, mannitol, sorbitol, dulcitol, iditol, isomalt, maltitol, or lactitol.
[0048] In other embodiments, the crosslinker or linker component comprises an isocyanate. In some embodiments, a linker component comprises a diisocyanate, such as a methylene diphenyl
diisocyanate (MDI), toluene diisocyanate (TDI), naphthalene diisocyanate (NDI), isophorone diisocyanate (IPDI), and/or hexamethylene diisocyanate (HDI). Non-limiting examples of diisocyanates suitable for use in some embodiments described herein include Lupranate® LP27, LP30, LP30D, M, MI, MS, MIO, M20, M20S, M20FB, M20HB, M20SB, M70L, MM103, MP102, MS, R2500, R2500U, T80-Type 1, T80-Type 2, TF2115, 78, 81, 219, 223, 227, 230, 234, 245, 259, 265, 266, 273, 275, 278, 280, 281, 5010, 5020, 5030, 5040, 5050, 5060, 5070, 5080, 5090, 5100, 5110, 5140, 5143, and 8020, which are all commercially available from BASF. Other non-limiting examples of diisocyanates suitable for use in some embodiments described herein include Suprasec® 2004, 2029, 5025, 7316, 7507, 9150, 9561, 9577, 9582, 9600, 9603, 9608, 9612, 9610, 9612, 9615, and 9616 as well as Rubinate® 1209, 1234, 1670, 1790, 1920, 9040, 9234, 9236, 9271, 9272, 9465, and 9511, which are all commercially available from Huntsman. Other major producers of diisocyanates include Bayer, BorsodChem, Dow, Mitsui, Nippon Polyurethane Industry and Yantai Wanhua.
[0049] Further, in some embodiments, a composition described herein comprises a plurality of crosslinkers or linker components. Any combination of crosslinkers not inconsistent with the objectives of the present invention may be used.
[0050] In addition, a first and/or second linker component or crosslinker described herein can be present in a composition or in a component (e.g., in a first or second component) in any amount not inconsistent with the objectives of the present disclosure. In some embodiments, for instance, a component comprises less than about 10 weight percent of the crosslinker based on the total weight of the component. In some embodiments, a component (e.g., a first or second component described herein) comprises less than about 5 weight percent, less than about 3 weight percent, less than about 2 weight percent, or less than about 1 weight percent of the crosslinker or linker component. In some embodiments, a component (e.g., a first or second component described herein) comprises between about 1 weight percent and about 5 weight percent of the crosslinker or between about 1 weight percent about 8 weight percent crosslinker. [0051] Further, in some implementations, a composition (or a first component and/or second component) described herein further comprises an ionic liquid. Any ionic liquid not inconsistent with the objectives of the present disclosure may be used. For example, in some cases, an ionic liquid is pyridinium-based. In other instances, the ionic liquid comprises a sugar or sugar alcohol. Non-limiting examples of ionic liquids which may be used in some embodiments
described herein include l-Allyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide, 1-Allyl- 3-methylimidazolium bromide, l-Allyl-3-methylimidazolium dicyanamide, l-Allyl-3- methylimidazolium iodide, l-Benzyl-3-methylimidazolium chloride, l-Benzyl-3- methylimidazolium hexafluorophosphate, l-Benzyl-3-methylimidazolium tetrafluoroborate, 1,3- Bis(3-cyanopropyl)imidazolium bi s(trifluorom ethyl sulfonyl)imide, 1,3-Bis(3- cyanopropyl)imidazolium chloride, l-Butyl-2,3-dimethylimidazolium hexafluorophosphate, 1- Butyl-2, 3-dimethylimidazolium tetrafluoroborate, 4-(3-Butyl-l-imidazolio)-l-butanesulfonate, 1- Butyl-3-methylimidazolium acetate, l-Butyl-3-methylimidazolium chloride, l-Butyl-3- methylimidazolium dibutyl phosphate, l-Butyl-3-methylimidazolium hexafluorophosphate, 1- Butyl-3-methylimidazolium nitrate, l-Butyl-3-methylimidazolium octyl sulfate, l-Butyl-3- methylimidazolium tetrachloroaluminate, l-Butyl-3-methylimidazolium tetrafluoroborate, 1- Butyl-3-methylimidazolium thiocyanate, l-Butyl-3-methylimidazolium tosylate, l-Butyl-3- methylimidazolium trifluoroacetate, l-Butyl-3-methylimidazolium trifluoromethanesulfonate, 1- (3-Cyanopropyl)-3-m ethy limidazolium bis(trifluoromethylsulfonyl)amide, l-Decyl-3- methylimidazolium tetrafluoroborate, 1,3- Diethoxyimidazolium bis(trifluoromethylsulfonyl)imide, 1,3 -Diethoxyimidazolium hexafluorophosphate, 1,3- Dihydroxyimidazolium bis(trifluoromethylsulfonyl)imide, 1,3- Dihydroxy-2-methylimidazolium bis(trifluoromethylsulfonyl)imide, 1,3 -Dimethoxy -2-methylimidazolium hexafluorophosphate, 1- Dodecyl-3-methylimidazolium iodide, l-Ethyl-2, 3-dimethylimidazolium tetrafluoroborate, 1- Ethyl-3-methylimidazolium hexafluorophosphate, 1-Ethy 1-3-methylimidazoli um L-(+)-lactate, 1-Ethy 1-3-methylimidazolium 1, 1,2,2-tetrafluoroethanesulfonate, l-Hexyl-3-methylimidazolium bis(trifluormethylsulfonyl)imide, l-Hexyl-3-methylimidazolium chloride, l-Hexyl-3- methylimidazolium hexafluorophosphate, 1-Methylimidazolium chloride, l-Methyl-3- octylimidazolium chloride, l-Methyl-3-octylimidazolium tetrafluoroborate, l-Methyl-3- propylimidazolium iodide, l-Methyl-3-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)imidazolium hexafluorophosphate, 1,2,3-Trimethylimidazolium methyl sulfate, l-Butyl-4-methylpyridinium chloride, l-Butyl-4-methylpyridinium hexafluorophosphate, 1 -Butylpyridinium bromide, l-(3- Cyanopropyl)pyridinium chloride, 1 -Ethylpyridinium tetrafluoroborate, 3-Methyl-l- propylpyridinium bis(trifluormethylsulfonyl)imide, Cholin acetate, glycol-choline, glycerolcholine, erythritol-choline, threitol-choline, arabitol-choline, xylitol-choline, ribitol-choline, mannitol-choline, sorbitol-choline, dulcitol-choline, iditol-choline, isomalt-choline, maltitol-
choline, or lactitol-choline, or a combination of two or more of the foregoing. Additionally, in some embodiments, one or more of the pH modulators may comprise or include an ionic liquid. [0052] An ionic liquid can be present in a first component and/or second component described herein in any amount not inconsistent with the technical objectives of the present disclosure. In some cases, for example, a first component and/or a second component comprises up to 10 wt. %, up to 7 wt. %, up to 5 wt. %, up to 2 wt. %, or up to 1 wt. % ionic liquid, based on the total weight of the first component and/or the second component, respectively. In some embodiments, a first component and/or a second component comprises 0.5-10 wt. %, 1-10 wt. %, 1-7 wt. %, 1-5 wt. %, 2-10 wt. %, 2-7 wt. %, 2-5 wt. %, 3-10 wt. %, 3-7 wt. %, 3-5 wt. %, 5-10 wt. %, or 5-7 wt. % ionic liquid, based on the total weight of the first component and/or the second component, respectively.
[0053] Additionally, in some embodiments, a composition (or a first component and/or second component) described herein further comprises a kinetic control agent. Use of a kinetic control agent, in some cases, can increase or decrease the rate of formation of a shape stable PCM described herein. Any kinetic control agent not inconsistent with the technical objectives of the present disclosure may be used. In some cases, a kinetic control agent comprises a zirconium compound, complex, or salt. For example, in some instances, a kinetic control agent comprises a zirconium halide or related species, such as zirconium oxychloride, zirconium hydroxychloride, zirconium tetrachloride, zirconium bromide, or a combination of two or more of the foregoing. In some embodiments, a kinetic control agent comprises a zirconium salt of a mineral acid, such as zirconium sulfate, basic zirconium sulfate, zirconium oxynitrate, zirconium oxy acetate, zirconium oxycarbonate, or a combination of two or more of the foregoing. In some instances, a kinetic control agent comprises a zirconium salt of an organic acid, such as zirconium formate, zirconium acetate, zirconium propionate, zirconium caprylate, zirconium stearate, zirconium lactate, zirconium nitrate, zirconium carbonate, zirconium octylate, zirconium citrate, zirconium phosphate, or a combination of two or more of the foregoing. In still other embodiments, a kinetic control agent described herein comprises a complex salt such as ammonium zirconium carbonate, ammonium zirconium phosphate, ammonium zirconium sulfate, ammonium zirconium oxalate, ammonium zirconium acetate, ammonium zirconium citrate, ammonium zirconium lactate, potassium zirconium carbonate, sodium zirconium sulfate,
sodium zirconium oxalate, sodium zirconium citrate, or a combination of two or more of the foregoing.
[0054] Moreover, in some cases, a kinetic control agent described herein comprises boric acid or a borate. For example, in some implementations, a kinetic control agent described herein comprises boric acid, calcium metaborate, kodalk or sodium metaborate, potassium metaborate, dipotassium tetraborate, sodium tetraborate, sodium metaborate tetrahydrate, sodium tetraborate decahydrate, or a combination of two or more of the foregoing. Additionally, in some embodiments, a kinetic control agent comprises a borate ore or mineral (e.g., in alkaline solution). In some such instances, a kinetic control agent comprises ulexite, raphite, nobleite (Nobleite), Gowerite, hydroborocalcite (Frolovite), colemanite, meyerhoffite, inyoite, pandermite, tertschite, ginorite (Ginorite), pinnoite, paternoite (Patemoite), kurnakovite (Kurnakovite), inderite, Preobazhenskite, hydroboracite (Hydroboracite), inderborite (Inderborite), heintzite (Heintzite) Vealchite, or a combination of two or more of the foregoing. [0055] A kinetic control agent, when used, can be present in a first component and/or second component described herein in any amount not inconsistent with the technical objectives of the present disclosure. In some cases, for example, a first component and/or a second component comprises up to 10 wt. %, up to 7 wt. %, up to 5 wt. %, up to 2 wt. %, or up to 1 wt. % kinetic control agent, based on the total weight of the first component and/or the second component, respectively. In some embodiments, a first component and/or a second component comprises 0.5-10 wt. %, 1-10 wt. %, 1-7 wt. %, 1-5 wt. %, 2-10 wt. %, 2-7 wt. %, 2-5 wt. %, 3-10 wt. %, 3- 7 wt. %, 3-5 wt. %, 5-10 wt. %, or 5-7 wt. % kinetic control agent, based on the total weight of the first component and/or the second component, respectively.
[0056] Moreover, in some implementations, a composition (or a first component and/or second component) described herein further comprises a filler (e.g., a solid filler). Any filler not inconsistent with the technical objectives of the present disclosure may be used. In some embodiments, for example, a filler comprises an inorganic material, such as an inorganic solid. In some such cases, a filler comprises SiCh, ZrCh, or TiCh. In some cases, a filler comprises CaO or MgO.
[0057] A filler, when used, can be present in a first component and/or second component described herein in any amount not inconsistent with the technical objectives of the present disclosure. In some cases, for example, a first component and/or a second component comprises
up to 10 wt. %, up to 7 wt. %, up to 5 wt. %, up to 2 wt. %, or up to 1 wt. % filler, based on the total weight of the first component and/or the second component, respectively. In some embodiments, a first component and/or a second component comprises 0.5-10 wt. %, 1-10 wt. %, 1-7 wt. %, 1-5 wt. %, 2-10 wt. %, 2-7 wt. %, 2-5 wt. %, 3-10 wt. %, 3-7 wt. %, 3-5 wt. %, 5-10 wt. %, or 5-7 wt. % filler, based on the total weight of the first component and/or the second component, respectively.
[0058] In addition, in some embodiments, the first component and/or the second component further comprises a fire retardant. Any fire retardant not inconsistent with the objectives of the present invention may be used. In some embodiments, a fire retardant comprises a foam. Further, in some cases, a fire retardant can comprise an organic composition or an inorganic composition. In some instances, a fire retardant comprises a phosphate, such as ammonium phosphate, trisodium phosphate, triphenyl phosphate, tricresylphosphate, tris(2-chloroethyl)phosphate, tris(2-chloro-l-(chloromethyl)ethyl)phosphate, tris(chloropropyl)phosphate, tris(l,3-dichloro-2- propyl (phosphate, or tetrekis(2-chlorethyl)dichloroisopentyldiphosphate. In some embodiments, a fire retardant comprises aluminum hydroxide and/or magnesium hydroxide.
[0059] A fire retardant may also comprise a zeolite. Any zeolite not inconsistent with the objectives of the present disclosure may be used. In some cases, a zeolite comprises a natural zeolite. In other embodiments, a zeolite comprises an artificial zeolite. In some instances, a zeolite comprises a silicate and/or aluminosilicate. In some implementations, a zeolite comprises a composition according to the formula Mv/„ [(AlCh SiChj l • vi’HiO, where n is the valence of cation M (e.g., Na+, K+, Ca2+, or Mg2+), w is the number of water molecules per unit cell, and x and j are the total number of tetrahedral atoms per unit cell. Non-limiting examples of zeolites suitable for use in some embodiments described herein include analcime ((K,Ca,Na)AlSi2Oe • H2O), chabazite ((Ca,Na2,K2,Mg)AhSi40i2 • 6H2O), clinoptilolite ((Na,K,Ca)2-3 Ah(Al, Si)2Si 13O36 • I2H2O), heulandite ((Ca,Na)2-3A13(Al,Si)2Sii3O36 • I2H2O), natrolite (Na2AhSi30io • 2H2O), phillipsite ((Ca,Na2,K2)3Al6Siio032 • 12H2O), and stilbite (NaCa4(Si27A19)O72 • 28H2O). [0060] A fire retardant, when used, can be present in a first component and/or second component described herein in any amount not inconsistent with the technical objectives of the present disclosure. In some cases, for example, a first component and/or a second component comprises up to 10 wt. %, up to 7 wt. %, up to 5 wt. %, up to 2 wt. %, or up to 1 wt. % fire retardant, based on the total weight of the first component and/or the second component,
respectively. In some embodiments, a first component and/or a second component comprises 0.5-10 wt. %, 1-10 wt. %, 1-7 wt. %, 1-5 wt. %, 2-10 wt. %, 2-7 wt. %, 2-5 wt. %, 3-10 wt. %, 3- 7 wt. %, 3-5 wt. %, 5-10 wt. %, or 5-7 wt. % fire retardant, based on the total weight of the first component and/or the second component, respectively.
[0061] A composition (or a first component and/or second component) described herein may also comprise a polymeric material (other than or different from a polysaccharide component described herein). Any polymeric material not inconsistent with the objectives of the present disclosure may be used. In some embodiments, a polymeric material comprises an organic composition. For example, in some cases, a polymeric material comprises a polyolefin such as polyethylene or polypropylene, a polycarbonate, a polyester, or a polyurethane. In some instances, a polymeric material comprises polyvinyl alcohol (PVA). In certain instances, a polymeric material comprises an acrylic acid-based polymer. For example, in some embodiments, an acrylic acid-based polymer described herein comprises poly(acrylic acid) (PAA) and/or an acrylic acid based copolymer.
[0062] An additional polymeric material, when used, can be present in a first component and/or second component described herein in any amount not inconsistent with the technical objectives of the present disclosure. In some cases, for example, a first component and/or a second component comprises up to 10 wt. %, up to 7 wt. %, up to 5 wt. %, up to 2 wt. %, or up to 1 wt. % polymeric material, based on the total weight of the first component and/or the second component, respectively. In some embodiments, a first component and/or a second component comprises 0.5-10 wt. %, 1-10 wt. %, 1-7 wt. %, 1-5 wt. %, 2-10 wt. %, 2-7 wt. %, 2-5 wt. %, 3- 10 wt. %, 3-7 wt. %, 3-5 wt. %, 5-10 wt. %, or 5-7 wt. % polymeric material, based on the total weight of the first component and/or the second component, respectively.
[0063] Turning to another possible additive, in some instances, the first component and/or the second component further comprises an antimicrobial material. Any antimicrobial material not inconsistent with the objectives of the present disclosure may be used. An antimicrobial material, in some cases, comprises an inorganic composition, including metals and/or metal salts. In some embodiments, for example, an antimicrobial material comprises metallic copper, zinc, or silver or a salt of copper, zinc, or silver. Moreover, in some instances, an antimicrobial material comprising a metal can also provide thermal conductivity modulation. In other embodiments, an antimicrobial material comprises an organic composition, including natural and synthetic organic
compositions. In some cases, an antimicrobial material comprises a P-lactam such as a penicillin or cephalosporin. In some implementations, an antimicrobial material comprises a protein synthesis inhibitor such as neomycin. In some embodiments, an antimicrobial material comprises an organic acid, such as lactic acid, acetic acid, or citric acid. In some cases, an antimicrobial material comprises a quarternary ammonium species. A quarternary ammonium species, in some embodiments, comprises a long alkyl chain, such as an alkyl chain having a C8 to C28 backbone. In some instances, an antimicrobial material comprises one or more of benzalkonium chloride, benzethonium chloride, methylbenzethonium chloride, cetalkonium chloride, cetylpyridinium chloride, cetrimonium, cetrimide, dofanium chloride, tetraethylammonium bromide, didecyldimethylammonium chloride, and domiphen bromide. Additionally, in some embodiments, one or more of a pH modulator and/or an ionic liquid may also be an antimicrobial material.
[0064] Moreover, in some implementations, the first component and/or the second component further comprises an organic phase change material (PCM). In some embodiments, an organic PCM comprises a fatty acid. In some such embodiments, a fatty acid can have a C4 to C28 aliphatic hydrocarbon tail. For reference purposes herein, it is to be understood that a “Cn-Cm” aliphatic hydrocarbon, alkyl, or similar alkylene moiety (e.g., a “C4-C28 aliphatic hydrocarbon or alkylene moiety”) is a bivalent saturated aliphatic radical having from “n” to “m” carbon atoms (e.g., 4 to 28 carbon atoms, and no more than 28 carbon atoms). Non-limiting examples of fatty acids suitable for use in some embodiments described herein include caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, arachidic acid, behenic acid, lignoceric acid, and cerotic acid. Further, in some embodiments, an oxidized fatty component described herein comprises a plurality of differing fatty acids.
[0065] In some embodiments, an organic PCM comprises an analogue of a fatty acid. In some instances, an analogue of a fatty acid comprises a fatty sulfonate or phosphonate. Any fatty sulfonate or phosphonate not inconsistent with the objectives of the present invention may be used. In some embodiments, an organic phase change material comprises a C4 to C28 alkyl sulfonate or phosphonate. In some embodiments, an organic phase change material comprises a C4 to C28 alkenyl sulfonate or phosphonate. Further, in some embodiments, an organic PCM comprises a polyethylene glycol. Any polyethylene glycol not inconsistent with the objectives of the present invention may be used.
[0066] In some instances, an organic PCM described herein comprises an alkyl ester of a fatty acid. Any alkyl ester not inconsistent with the objectives of the present invention may be used. For instance, in some embodiments, an alkyl ester comprises a methyl, ethyl, propyl, or butyl ester of a fatty acid described herein. In other embodiments, an alkyl ester comprises a C2 to C6 ester alkyl backbone or a C6 to C12 ester alkyl backbone. In some embodiments, an alkyl ester comprises a C12 to C28 ester alkyl backbone. Further, in some embodiments, an organic PCM described herein comprises a plurality of differing alkyl esters of fatty acids. Non-limiting examples of alkyl esters of fatty acids suitable for use in some embodiments described herein include methyl laurate, methyl myristate, methyl palmitate, methyl stearate, methyl palmitoleate, methyl oleate, methyl linoleate, methyl docosahexanoate, and methyl ecosapentanoate. In some embodiments, the corresponding ethyl, propyl, or butyl esters may also be used.
[0067] In addition, in some embodiments, an organic phase change material described herein comprises a fatty alcohol. Any fatty alcohol not inconsistent with the objectives of the present invention may be used. For instance, a fatty alcohol, in some embodiments, can have a C4 to C28 aliphatic hydrocarbon tail. Further, in some embodiments, the hydrocarbon tail is saturated. Alternatively, in other embodiments, the hydrocarbon tail is unsaturated. In some embodiments, the hydrocarbon tail can be branched or linear. Non-limiting examples of fatty alcohols suitable for use in some embodiments described herein include capryl alcohol, pelargonic alcohol, capric alcohol, undecyl alcohol, lauryl alcohol, tridecyl alcohol, myristyl alcohol, pentadecyl alcohol, cetyl alcohol, heptadecyl alcohol, stearyl alcohol, nonadecyl alcohol, arachidyl alcohol, heneicosyl alcohol, behenyl alcohol, lignoceryl alcohol, ceryl alcohol, and montanyl alcohol. Further, in some embodiments, an oxidized fatty component described herein comprises a plurality of differing fatty alcohols.
[0068] Further, an organic PCM component, in some embodiments, comprises a mixture or combination of one or more fatty acids, fatty alcohols, and/or alkyl esters of fatty acids described herein. Any combination not inconsistent with the objectives of the present invention may be used. In some embodiments, for example, an organic PCM component comprises one or more fatty acids and one or more fatty alcohols.
[0069] In addition, in some implementations, the first component and/or the second component further comprises an inorganic PCM component. In some embodiments, an inorganic component comprises a salt hydrate. Suitable salt hydrates include, without limitation, CaCh •
6H2O and/or other CaCh hydrates, Ca(NO3)2 • 3H2O, NaSCh • 10H2O, Na(NO3)2 • 6H2O, Zn(NO3)2 • 2H2O, FeCh • 2 H2O, Co(NO3)2 • 6H2O, Ni(NO3)2 ’6H2O, MnCh • 4H2O, CH3COONa • 3H2O, LiC2H3O2 • 2H2O, MgCl2 • 4H2O, NaOH • H2O, Cd(NO3)2 • 4H2O, Cd(NO3)2 • 1H2O, Fe(NO3)2 • 6H2O, NaAl(SO4)2 • 12H2O, FeSCh • 7H2O, Na3PO4 • 12H2O, Na2B4O7 • IOH2O, Na3PO • 12H2O, LiCH3COO • 2H2O, NH4Br hydrates, KBr hydrates, NaBr hydrates, CaBn hydrates, and/or mixtures thereof. If a first component and/or second component comprises water, the anhydrous salt can also be used, in some cases. Further, in some embodiments, the first component and/or the second component further comprises an inorganic PCM component and an organic PCM.
[0070] Moreover, in some instances, the first component and/or the second component further comprises a pH modulator. A pH modulator can be acidic or basic, in the sense of lowering/decreasing or raising/increasing the pH of the component. For example, in some embodiments, the pH modulator lowers the pH of the shape stable phase change material composition, compared to what the pH would be if the pH modulator were absent (or of a precursor mixture of the composition). In other instances, the pH modulator raises the pH of the composition, compared to what the pH would be if the pH modulator were absent. Any pH modulator not inconsistent with the objectives of the present disclosure may be used. For example, in some cases, the pH modulator comprises an organic acid or an organic base. In some such cases, the pH modulator comprises citric acid, a citrate salt (such as mono-, di-, or tri-sodium citrate), lactic acid, a salt of lactic acid, or acetic acid. In other embodiments, the pH modulator comprises an inorganic acid or base. For example, an inorganic acid comprises HC1, H2SO4, or HN03, and an inorganic base comprises NaOH or KOH. Further, in some cases, a first component or second component described herein comprises or contains more than one pH modulator. In some such instances, the first component and/or the second component described herein comprises at least two pH modulators. A first pH modulator, in some embodiments, lowers the pH of the shape stable phase change material composition. In certain other embodiments, the first pH modulator raises the pH of the composition. Correspondingly, a second pH modulator may be selected to further modify the pH of the composition in combination with the first pH modulator. For example, a second pH modulator may further lower the pH of the shape stable phase change material composition where the first pH modulator lowers the pH of the composition. Alternatively, a second pH modulator may raise the pH of the shape stable phase change material composition while the first pH
modulator lowers the pH of the composition. Similarly, where the first pH modulator raises a pH of the composition, the second pH modulator may also raise the pH of the shape stable phase change material composition or may lower the pH of the composition.
[0071] As described herein, in some embodiments, a first component and/or a second component comprises a catalyzing agent. In some such instances, the catalyzing agent can be a pH modulator or kinetic control agent described hereinabove. Additionally, in some preferred embodiments, the first component comprises a first catalyzing agent, and the second component comprises a second catalyzing agent. Moreover, in some such cases, the first catalyzing agent increases the rate of crosslinking of components to form the shape stable PCM, upon contact of the first component with the second component, but not before. For example, in some such implementations, the first catalyzing agent can initiate or increase the rate of reaction or crosslinking of a material that is present in the second component but not in the first component. Similarly, in some instances, the second catalyzing agent (which is present in the second component but not the first component) increases the rate of crosslinking of components to form the shape stable PCM, upon contact of the first component with the second component, but not before. For example, in some such implementations, the second catalyzing agent can initiate or increase the rate of reaction or crosslinking of a material that is present in the first component but not in the second component. Therefore, in some exemplary embodiments, the first component described herein comprises a first catalyzing agent and a first crosslinker, and the second component comprises a second catalyzing agent and a second crosslinker. Additionally, in some such cases, the first catalyzing agent (present in the first component) initiates or increases the rate of crosslinking carried out by the second crosslinker (present in the second component), but does not initiate or increase the rate of crosslinking carried out by the first crosslinker (present in the first component). Further, in some such embodiments, the second catalyzing agent (present in the second component) initiates or increases the rate of crosslinking carried out by the first crosslinker (present in the first component), but does not initiate or increase the rate of crosslinking carried out by the second crosslinker (present in the second component).
[0072] It is further to be understood that, in some instances, a composition or a first component and/or second component described herein can comprise water in addition to other species or materials. In some instances, water is present in a composition or a first component and/or second component described herein as the “balance” making up 100 wt. % in combination
with other species or materials present. In some cases, a composition or a first component and/or second component described herein comprises up to 95 wt. %, up to 90 wt. %, up to 85 wt. %, up to 80 wt. %, up to 75 wt. %, or up to 70 wt. % water, based on the total weight of the composition, first component, and/or second component, respectively. In some instances, a composition or a first component and/or second component described herein comprises 10-95 wt. %, 10-90 wt. %, 10-85 wt. %, 10-80 wt. %, 10-75 wt. %, 10-70 wt. %, 10-60 wt. %, 10-50 wt. %, 10-40 wt. %, 10-30 wt. %, 20-95 wt. %, 20-90 wt. %, 20-85 wt. %, 20-80 wt. %, 20-75 wt. %, 20-70 wt. %, 20-60 wt. %, 20-50 wt. %, 20-40 wt. %, 20-30 wt. %, 30-95 wt. %, 30-90 wt. %, 30-85 wt. %, 30-80 wt. %, 30-75 wt. %, 30-70 wt. %, 30-60 wt. %, 30-50 wt. %, 30-40 wt. %, 40-95 wt. %, 40-90 wt. %, 40-85 wt. %, 40-80 wt. %, 40-75 wt. %, 40-70 wt. %, 40-60 wt. %, 50-95 wt. %, 50-90 wt. %, 50-85 wt. %, 50-80 wt. %, 50-75 wt. %, 50-70 wt. %, 60-95 wt. %, 60-90 wt. %, 60-85 wt. %, 60-80 wt. %, 60-75 wt. %, or 60-70 wt. % water, based on the total weight of the composition, first component, and/or second component, respectively.
[0073] Some embodiments described herein are further illustrated in the following nonlimiting examples.
EXAMPLES
Methods of Forming PCM Compositions
[0074] Various PCM compositions are formed using the components indicated in Tables 2-6. Table 2 provides non-limiting examples of a first component described herein. In Table 2, for each example First Component (“First Comp.” or “FC” in Table 2), the weight percents (based on a total weight of 100 wt. % of the first component) for various materials or subcomponents are provided. That is, the values in Table 2 are the weight percents of the identified materials and subcomponents. In Table 2, “Linker” refers to a crosslinker; “pHM” refers to pH modulator;
“KCA” refers to kinetic control agent; “Filler” refers to a filler; “Ion. Liq.” refers to ionic liquid; “FR” refers to fire retardant; “PM” refers to polymeric material; “AM” refers to antimicrobial material; “APCM” refers to additional PCM, wherein the PCM comprises an organic PCM or an inorganic PCM; and “Cat.” refers to catalyzing agent. Hyphens (“— ”) indicate the absence of a material. Table 3 provides the identities of the various subcomponents of the First Components from Table 2. In Table 3, “polysacch.” refers to a polysaccharide; “Zr” refers to zirconium compound or complex; “BA” refers to boric acid; “BO” refers to borate; “zeol.” refers to zeolite;
“FRF” refers to fire retardant foam; “AMOC” refers to an antimicrobial organic composition; “pyr.” refers to pyridinium based ionic liquid; “chol ” refers to choline-containing ionic liquid. “ORC” refers to an organocatalyst. In Tables 2 and 3, the balance to make 100 wt. % is water. [0075] Similarly, Table 4 provides non-limiting examples of a second component described herein. In Table 4, for each example Second Component (“Sec. Comp.” or “SC” in Table 4), the weight percents (based on a total weight of 100 wt. % of the second component) for various materials or subcomponents are provided, using the same abbreviations as in Tables 2 and 3. That is, the values in Table 4 are the weight percents of the identified materials and subcomponents. Table 5 provides the identities of the various subcomponents of the Second Components from Table 4, using the same abbreviations as in Table 3. In Tables 4 and 5, the balance to make 100 wt. % is water.
[0076] Table 6 provides combinations (“Comb.” in Table 6) of specific First Components with specific Second Components from Tables 2-5. In general, for the Examples below, a first fluid stream containing the first component and a second fluid stream containing the second component intersect in a homogenization chamber to provide the crosslinking matrix. The complete or substantially complete homogenization of the first and second components occurs within the homogenization chamber and before leaving the homogenization chamber. The resulting PCM composition is dispensed into a reaction vessel.
[0077] Certain additional example implementations of embodiments consistent with the present disclosure are as follows.
[0078] Embodiment 1. A method of forming a shape stable phase change material, the method comprising: combining a first component and a second component to provide a crosslinking matrix; and dispensing the crosslinking matrix into a reaction vessel under conditions whereby the crosslinking matrix crosslinks to form the shape stable phase change material, wherein the conditions whereby the crosslinking matrix crosslinks to form the shape stable phase change material comprise a period of time between 1 second and 100 hours; wherein the first component is flowable at temperatures above 0°C at 1 atm; wherein the second component is flowable at temperatures above 0°C at 1 atm; and wherein the shape stable phase change material is shape stable at temperatures above 0°C at 1 atm.
[0079] Embodiment 2. The method of Embodiment 1, wherein the crosslinking matrix comprises a polyol.
[0080] Embodiment 3. The method of Embodiment 1 or Embodiment 2, wherein the crosslinking matrix comprises a saccharide and the saccharide comprises a monosaccharide, disaccharide, oligosaccharide, or polysaccharide.
[0081] Embodiment 4. The method of any of Embodiments 1-3, wherein the crosslinking matrix comprises a sugar alcohol and the sugar alcohol comprises glycol, glycerol, erythritol, threitol, arabitol, xylitol, ribitol, mannitol, sorbitol, dulcitol, iditol, isomalt, maltitol, or lactitol.
[0082] Embodiment 5. The method of any of Embodiments 1-4, wherein combining the first component and the second component to provide the crosslinking matrix comprises combining the first component and the second component in a ratio of the first component to the second component of between about 70:30 and about 90: 10 by volume.
[0083] Embodiment 6. The method of any of Embodiments 1-4, wherein combining the first component and the second component to provide the crosslinking matrix comprises combining the first component and the second component in a ratio of the first component to the second component of between about 70:30 and about 85: 15 by volume.
[0084] Embodiment 7. The method of any of Embodiments 1-4, wherein combining the first component and the second component to provide the crosslinking matrix comprises combining the first component and the second component in a ratio of the first component to the second component of between about 70:30 and about 80:20 by volume.
[0085] Embodiment 8. The method of any of Embodiments 1-4, wherein combining the first component and the second component to provide the crosslinking matrix comprises combining the first component and the second component in a ratio of the first component to the second component of about 75:25 by volume.
[0086] Embodiment 9. The method of any of Embodiments 1-8, wherein combining the first component and the second component to provide the crosslinking matrix comprises adding the first component in a first fluid stream and adding the second component in a second fluid stream.
[0087] Embodiment 10. The method of Embodiment 9, wherein combining the first component and the second component to provide the crosslinking matrix comprises directing the first fluid stream and the second fluid stream to intersect in a homogenization chamber.
[0088] Embodiment 11. The method of Embodiment 10, wherein the homogenization chamber is suspended above the reaction vessel.
[0089] Embodiment 12. The method of Embodiment 11, wherein dispensing the crosslinking matrix into the reaction vessel comprises gravity feeding the crosslinking matrix from the homogenization chamber to the reaction vessel.
[0090] Embodiment 13. The method of Embodiment 10, wherein the first fluid stream is flowed towards the homogenization chamber through a first nozzle and the second fluid stream is flowed towards the homogenization chamber through a second nozzle.
[0091] Embodiment 14. The method of Embodiment 13, wherein the first nozzle has a first diameter, the second nozzle has a second diameter, and a ratio of the first diameter to the second diameter corresponds to a volumetric ratio of the first component to the second component, within 10%.
[0092] Embodiment 15. The method of Embodiment 14, wherein the ratio of the first diameter to the second diameter is between about 70:30 and about 90: 10 or between about 70:30 and 85: 15.
[0093] Embodiment 16. The method of Embodiment 14, wherein the ratio of the first diameter to the second diameter is between about 70:30 and 80:20.
[0094] Embodiment 17. The method of Embodiment 14, wherein the ratio of the first diameter to the second diameter is about 75:25.
[0095] Embodiment 18. The method of any of Embodiments 1-17, wherein the first component comprises at least a first linker component and the second component comprises at least a second linker component which can crosslink to form the shape stable phase change material.
[0096] Embodiment 19. The method of Embodiment 18, wherein the first linker component and the second linker component crosslink to form the shape stable phase change material over a period of at least 1 hour at 0°C and 1 atm in the absence of the second component, and over a period of less than 1 hour, less than 30 minutes, less than 15 minutes, or less than 5 minutes at 0°C and 1 atm in the presence of the second component.
[0097] Embodiment 20. The method of Embodiment 18, wherein the first linker component and the second linker component crosslink to form the shape stable phase change material over a period of at least 3 hours at 0°C and 1 atm in the absence of the second component, and over a period of less than 3 hours, less than 2 hours, less than 1 hour, less than 30 minutes, less than 15 minutes, or less than 5 minutes at 0°C and 1 atm in the presence of the second component.
[0098] Embodiment 21. The method of Embodiment 18, wherein the first component or the second component comprises at least one catalyzing agent operable to increase a rate of crosslinking between the first linker component and the second linker component.
[0099] Embodiment 22. The method of any of Embodiments 1-21, wherein the first component or the second component comprises at least one pH modulator.
[00100] All patent documents referred to herein are incorporated by reference in their entireties. Various embodiments of the invention have been described in fulfdlment of the various objectives of the invention. It should be recognized that these embodiments are merely illustrative of the principles of the present invention. Numerous modifications and adaptations thereof will be readily apparent to those skilled in the art without departing from the spirit and scope of the invention.
Claims
1. A method of forming a shape stable phase change material, the method comprising: combining a first component and a second component to provide a crosslinking matrix; and dispensing the crosslinking matrix into a reaction vessel under conditions whereby the crosslinking matrix crosslinks to form the shape stable phase change material, wherein the conditions whereby the crosslinking matrix crosslinks to form the shape stable phase change material comprise a period of time between 1 second and 100 hours; wherein the first component is flowable at temperatures above 0°C at 1 atm; wherein the second component is flowable at temperatures above 0°C at 1 atm; and wherein the shape stable phase change material is shape stable at temperatures above 0°C at 1 atm.
2. The method of claim 1, wherein the crosslinking matrix comprises a polyol.
3. The method of claim 1, wherein the crosslinking matrix comprises a monosaccharide, disaccharide, oligosaccharide, or polysaccharide.
4. The method of claim 1, wherein the crosslinking matrix comprises glycerol, erythritol, threitol, arabitol, xylitol, ribitol, mannitol, sorbitol, dulcitol, iditol, isomalt, maltitol, or lactitol.
5. The method of claim 1, wherein combining the first component and the second component to provide the crosslinking matrix comprises combining the first component and the second component in a ratio of the first component to the second component of between about 70:30 and about 90: 10 by volume.
6. The method of claim 1, wherein combining the first component and the second component to provide the crosslinking matrix comprises combining the first component and the second component in a ratio of the first component to the second component of between about 70:30 and about 85: 15 by volume.
7. The method of claim 1, wherein combining the first component and the second component to provide the crosslinking matrix comprises combining the first component and the second component in a ratio of the first component to the second component of between about 70:30 and about 80:20 by volume.
8. The method of claim 1, wherein combining the first component and the second component to provide the crosslinking matrix comprises combining the first component and the second component in a ratio of the first component to the second component of about 75:25 by volume.
9. The method of claim 1, wherein combining the first component and the second component to provide the crosslinking matrix comprises adding the first component in a first fluid stream and adding the second component in a second fluid stream.
10. The method of claim 9, wherein combining the first component and the second component to provide the crosslinking matrix comprises directing the first fluid stream and the second fluid stream to intersect in a homogenization chamber.
11. The method of claim 10, wherein the homogenization chamber is suspended above the reaction vessel.
12. The method of claim 11, wherein dispensing the crosslinking matrix into the reaction vessel comprises gravity feeding the crosslinking matrix from the homogenization chamber to the reaction vessel.
13. The method of claim 10, wherein the first fluid stream is flowed towards the homogenization chamber through a first nozzle and the second fluid stream is flowed towards the homogenization chamber through a second nozzle.
14. The method of claim 13, wherein the first nozzle has a first diameter, the second nozzle has a second diameter, and a ratio of the first diameter to the second diameter corresponds to a volumetric ratio of the first component to the second component, within 10%.
15. The method of claim 14, wherein the ratio of the first diameter to the second diameter is between about 70:30 and about 90: 10 or between about 70:30 and 85: 15.
16. The method of claim 14, wherein the ratio of the first diameter to the second diameter is between about 70:30 and 80:20.
17. The method of claim 14, wherein the ratio of the first diameter to the second diameter is about 75:25.
18. The method of claim 1, wherein the first component comprises at least a first linker component and at least a second linker component which can crosslink to form the shape stable phase change material.
19. The method of claim 18, wherein the first linker component and the second linker component crosslink to form the shape stable phase change material over a period of at least 1 hour at 0°C and 1 atm in the absence of the second component, and over a period of less than 15 minutes at 0°C and 1 atm in the presence of the second component.
20. The method of claim 18, wherein the first linker component and the second linker component crosslink to form the shape stable phase change material over a period of at least 3 hours at 0°C and 1 atm in the absence of the second component, and over a period of less than 30 minutes at 0°C and 1 atm in the presence of the second component.
21. The method of claim 18, wherein the first component or the second component comprises at least one catalyzing agent operable to increase a rate of crosslinking between the first linker component and the second linker component.
22. The method of claim 1, wherein the first component or the second component comprises at least one pH modulator.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202263423832P | 2022-11-09 | 2022-11-09 | |
US63/423,832 | 2022-11-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024102900A1 true WO2024102900A1 (en) | 2024-05-16 |
Family
ID=91033603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2023/079215 WO2024102900A1 (en) | 2022-11-09 | 2023-11-09 | Methods of making shape stable phase change material compositions |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024102900A1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110210280A1 (en) * | 2008-09-11 | 2011-09-01 | Saint-Gobain Isover | Sizing composition for mineral wool based on hydrogenated sugar and insulating products obtained |
US20130034732A1 (en) * | 2009-01-20 | 2013-02-07 | Pcm Innovations Llc | Phase change material-containing composition and related products and methods |
US20180215981A1 (en) * | 2015-07-31 | 2018-08-02 | Egc Enterprises, Inc. | Shape stabilized phase-change material for heat retentive applications |
WO2019225675A1 (en) * | 2018-05-25 | 2019-11-28 | 三菱ケミカルエンジニアリング株式会社 | Reaction product manufacturing device and reaction product manufacturing method |
US20210197145A1 (en) * | 2019-07-04 | 2021-07-01 | Japan Atomic Energy Agency | Nozzle for Liquid Phase Ejection |
WO2021174040A1 (en) * | 2020-02-28 | 2021-09-02 | Phase Change Energy Solutions, Inc. | Compositions containing phase change materials and systems including the same |
-
2023
- 2023-11-09 WO PCT/US2023/079215 patent/WO2024102900A1/en unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110210280A1 (en) * | 2008-09-11 | 2011-09-01 | Saint-Gobain Isover | Sizing composition for mineral wool based on hydrogenated sugar and insulating products obtained |
US20130034732A1 (en) * | 2009-01-20 | 2013-02-07 | Pcm Innovations Llc | Phase change material-containing composition and related products and methods |
US20180215981A1 (en) * | 2015-07-31 | 2018-08-02 | Egc Enterprises, Inc. | Shape stabilized phase-change material for heat retentive applications |
WO2019225675A1 (en) * | 2018-05-25 | 2019-11-28 | 三菱ケミカルエンジニアリング株式会社 | Reaction product manufacturing device and reaction product manufacturing method |
US20210197145A1 (en) * | 2019-07-04 | 2021-07-01 | Japan Atomic Energy Agency | Nozzle for Liquid Phase Ejection |
WO2021174040A1 (en) * | 2020-02-28 | 2021-09-02 | Phase Change Energy Solutions, Inc. | Compositions containing phase change materials and systems including the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11999896B2 (en) | Compositions comprising latent heat storage materials and methods of making the same | |
EP0402304B1 (en) | Latent heat storage materials and their use | |
CA2321904C (en) | Fire retardant concentrates and methods for preparation thereof and the like | |
NO812926L (en) | DISPERSIBLE HYDROPHILE POLYMER COMPOSITIONS | |
US4439333A (en) | Heavy brine viscosifiers | |
WO2024102900A1 (en) | Methods of making shape stable phase change material compositions | |
CA3004070A1 (en) | Starch suspension for adhesive coatings | |
EP0861120B8 (en) | Oil-free, water-soluble, hydroxyethyl cellulose, liquid, polymer dispersion | |
JP2017031361A (en) | Composition for aqueous adhesion | |
GB2196015A (en) | Dispersible hydrophilic polymer compositions for use in viscosifying heavy brines | |
WO2021150622A1 (en) | Thermal energy storage compositions and methods of using the same | |
CA1202477A (en) | Low fluid loss heavy brines containing hydroxyethyl cellulose | |
WO2024112532A1 (en) | Formulation for starch-based adhesives | |
US20230203358A1 (en) | Phase change polysaccharide-based bio-complexes with tunable thermophysical properties and preparation method thereof | |
WO2024081696A2 (en) | Compositions containing phase change materials, methods for forming objects using the same, and method for using the same | |
CN117502438A (en) | Synergistic bactericidal water suspension agent and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23889707 Country of ref document: EP Kind code of ref document: A1 |